AU2012201658A1 - Method of detecting allergen - Google Patents
Method of detecting allergen Download PDFInfo
- Publication number
- AU2012201658A1 AU2012201658A1 AU2012201658A AU2012201658A AU2012201658A1 AU 2012201658 A1 AU2012201658 A1 AU 2012201658A1 AU 2012201658 A AU2012201658 A AU 2012201658A AU 2012201658 A AU2012201658 A AU 2012201658A AU 2012201658 A1 AU2012201658 A1 AU 2012201658A1
- Authority
- AU
- Australia
- Prior art keywords
- flour
- gliadin
- native
- allergens
- denatured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 205
- 238000000034 method Methods 0.000 title claims abstract description 117
- 235000013312 flour Nutrition 0.000 claims abstract description 117
- 108010061711 Gliadin Proteins 0.000 claims abstract description 113
- 235000013305 food Nutrition 0.000 claims abstract description 65
- 210000004408 hybridoma Anatomy 0.000 claims description 101
- 238000003118 sandwich ELISA Methods 0.000 claims description 77
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 27
- 239000003398 denaturant Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 238000003317 immunochromatography Methods 0.000 claims description 20
- 101000951145 Homo sapiens Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Proteins 0.000 claims description 19
- 101000654245 Homo sapiens Succinate dehydrogenase assembly factor 2, mitochondrial Proteins 0.000 claims description 19
- 102100038014 Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial Human genes 0.000 claims description 19
- 102100031715 Succinate dehydrogenase assembly factor 2, mitochondrial Human genes 0.000 claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 abstract description 99
- 102000004169 proteins and genes Human genes 0.000 abstract description 99
- 108090000623 proteins and genes Proteins 0.000 abstract description 99
- 241000219051 Fagopyrum Species 0.000 abstract description 85
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract description 85
- 238000001514 detection method Methods 0.000 abstract description 76
- 244000105624 Arachis hypogaea Species 0.000 abstract description 74
- 235000020232 peanut Nutrition 0.000 abstract description 74
- 235000017060 Arachis glabrata Nutrition 0.000 abstract description 72
- 235000010777 Arachis hypogaea Nutrition 0.000 abstract description 72
- 235000018262 Arachis monticola Nutrition 0.000 abstract description 72
- 239000005018 casein Substances 0.000 abstract description 70
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 70
- 235000021240 caseins Nutrition 0.000 abstract description 70
- 235000013336 milk Nutrition 0.000 abstract description 51
- 210000004080 milk Anatomy 0.000 abstract description 51
- 239000008267 milk Substances 0.000 abstract description 50
- 108010064983 Ovomucin Proteins 0.000 abstract description 39
- 230000035945 sensitivity Effects 0.000 abstract description 36
- 230000001900 immune effect Effects 0.000 abstract description 23
- 102000007544 Whey Proteins Human genes 0.000 abstract description 18
- 108010046377 Whey Proteins Proteins 0.000 abstract description 18
- 239000005862 Whey Substances 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 110
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 94
- 244000005700 microbiome Species 0.000 description 85
- 210000004027 cell Anatomy 0.000 description 83
- 235000019750 Crude protein Nutrition 0.000 description 77
- 102000011632 Caseins Human genes 0.000 description 68
- 108010076119 Caseins Proteins 0.000 description 68
- 241000699666 Mus <mouse, genus> Species 0.000 description 68
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 66
- 239000004202 carbamide Substances 0.000 description 66
- 238000012360 testing method Methods 0.000 description 54
- 239000000523 sample Substances 0.000 description 51
- 230000003053 immunization Effects 0.000 description 46
- 239000000427 antigen Substances 0.000 description 45
- 102000036639 antigens Human genes 0.000 description 45
- 108091007433 antigens Proteins 0.000 description 45
- 238000002649 immunization Methods 0.000 description 45
- 239000000203 mixture Substances 0.000 description 41
- 238000002965 ELISA Methods 0.000 description 40
- 235000013372 meat Nutrition 0.000 description 39
- 229940092253 ovalbumin Drugs 0.000 description 39
- 239000013568 food allergen Substances 0.000 description 37
- 238000004113 cell culture Methods 0.000 description 35
- 238000005516 engineering process Methods 0.000 description 35
- 230000009257 reactivity Effects 0.000 description 35
- 238000002360 preparation method Methods 0.000 description 32
- 241000287523 Ara Species 0.000 description 31
- 239000007853 buffer solution Substances 0.000 description 30
- 239000012980 RPMI-1640 medium Substances 0.000 description 29
- 239000000839 emulsion Substances 0.000 description 28
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 28
- 108010058846 Ovalbumin Proteins 0.000 description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 239000008188 pellet Substances 0.000 description 27
- 238000005119 centrifugation Methods 0.000 description 26
- 239000012528 membrane Substances 0.000 description 26
- 239000011734 sodium Substances 0.000 description 25
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 24
- 235000013622 meat product Nutrition 0.000 description 24
- 229910052708 sodium Inorganic materials 0.000 description 24
- 238000012546 transfer Methods 0.000 description 24
- 238000011725 BALB/c mouse Methods 0.000 description 23
- 239000002671 adjuvant Substances 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 21
- 210000003567 ascitic fluid Anatomy 0.000 description 21
- 210000004989 spleen cell Anatomy 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 238000013207 serial dilution Methods 0.000 description 20
- 210000002966 serum Anatomy 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 102100022239 Peroxiredoxin-6 Human genes 0.000 description 18
- 101800001016 Picornain 3C-like protease Proteins 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- 238000010790 dilution Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 18
- 238000010438 heat treatment Methods 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000006228 supernatant Substances 0.000 description 18
- 102100036164 Putative phospholipase B-like 2 Human genes 0.000 description 17
- 101710200837 Putative phospholipase B-like 2 Proteins 0.000 description 17
- 238000003556 assay Methods 0.000 description 17
- 239000002609 medium Substances 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 239000002994 raw material Substances 0.000 description 15
- 239000011780 sodium chloride Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 241000283690 Bos taurus Species 0.000 description 14
- 229930182555 Penicillin Natural products 0.000 description 14
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 14
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 14
- 239000006285 cell suspension Substances 0.000 description 14
- 239000012228 culture supernatant Substances 0.000 description 14
- 239000012153 distilled water Substances 0.000 description 14
- 230000001605 fetal effect Effects 0.000 description 14
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 14
- 229940049954 penicillin Drugs 0.000 description 14
- 229960005322 streptomycin Drugs 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 239000011491 glass wool Substances 0.000 description 13
- 230000036963 noncompetitive effect Effects 0.000 description 13
- 239000012085 test solution Substances 0.000 description 13
- 238000004891 communication Methods 0.000 description 12
- 206010035226 Plasma cell myeloma Diseases 0.000 description 11
- 230000007910 cell fusion Effects 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 201000000050 myeloid neoplasm Diseases 0.000 description 11
- 235000021119 whey protein Nutrition 0.000 description 11
- 238000012258 culturing Methods 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 239000012460 protein solution Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 238000010532 solid phase synthesis reaction Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 8
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 235000008429 bread Nutrition 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 7
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 7
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 7
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- 241000725101 Clea Species 0.000 description 7
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 7
- 108060003951 Immunoglobulin Proteins 0.000 description 7
- 239000000020 Nitrocellulose Substances 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 101710120037 Toxin CcdB Proteins 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 229960003896 aminopterin Drugs 0.000 description 7
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 7
- 230000006287 biotinylation Effects 0.000 description 7
- 238000007413 biotinylation Methods 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 238000007710 freezing Methods 0.000 description 7
- 230000008014 freezing Effects 0.000 description 7
- 102000018358 immunoglobulin Human genes 0.000 description 7
- 238000010253 intravenous injection Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 229920001220 nitrocellulos Polymers 0.000 description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000006152 selective media Substances 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 229940104230 thymidine Drugs 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 6
- 210000000628 antibody-producing cell Anatomy 0.000 description 6
- 239000012620 biological material Substances 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000007791 liquid phase Substances 0.000 description 5
- 239000002075 main ingredient Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 101100313377 Caenorhabditis elegans stip-1 gene Proteins 0.000 description 4
- 101100313382 Dictyostelium discoideum stip-2 gene Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 102000008192 Lactoglobulins Human genes 0.000 description 4
- 108010060630 Lactoglobulins Proteins 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- 101100516335 Rattus norvegicus Necab1 gene Proteins 0.000 description 4
- 101150059016 TFIP11 gene Proteins 0.000 description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 235000021245 dietary protein Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000004445 quantitative analysis Methods 0.000 description 4
- 238000012113 quantitative test Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000010378 sodium ascorbate Nutrition 0.000 description 4
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 4
- 229960005055 sodium ascorbate Drugs 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 3
- 101100214637 Arabidopsis thaliana PGL4 gene Proteins 0.000 description 3
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 241001317287 Laccocephalum mylittae Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000008351 acetate buffer Substances 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000019830 sodium polyphosphate Nutrition 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- AUKMKXXKWVZIKK-UHFFFAOYSA-N 1-chloroimidazole Chemical compound ClN1C=CN=C1 AUKMKXXKWVZIKK-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 208000004262 Food Hypersensitivity Diseases 0.000 description 2
- 206010016946 Food allergy Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 101100494762 Mus musculus Nedd9 gene Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000020932 food allergy Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000000941 radioactive substance Substances 0.000 description 2
- 239000012723 sample buffer Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 102100033639 Acetylcholinesterase Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical class C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- 101001053670 Gallus gallus Ovomucoid Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 101000934888 Homo sapiens Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 102100025393 Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007500 overflow downdraw method Methods 0.000 description 1
- 229950009506 penicillinase Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108060006184 phycobiliprotein Proteins 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- FQIYBGJSPWHUQN-UHFFFAOYSA-N sulfanyloxymethane Chemical compound COS FQIYBGJSPWHUQN-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention provides an immunological detection method that can detect milk allergens, allergens 5 of albumen, flour, buckwheat and peanut with high sensitivity in foods containing these allergens regardless they are denatured/native, and a detection kit to be used therefor. It is a method for detecting allergens by using 2 or more monoclonal antibodies 10 recognizing native and denatured milk allergens, native and denatured albumen allergens, native and denatured flour allergens, native and denatured buckwheat allergens, and native and denatured peanut allergens, using xsl casein which is the main protein of milk casein, 15 P-lactoglobulin which is the main protein of whey, ovalubumin and ovomucoid which are main proteins of albumen, gliadin which is the main protein of flour, protein with a molecular weight of 24kDa and 76kDa which are main proteins of buckwheat, and Ara hl which is the 20 main protein of peanut as an index.
Description
Regulation 3.2 AUSTRALIA PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT ORIGINAL Name of Applicant: Prima Meat Packers, Ltd. Actual Inventors: Masanobu Akimoto Shigeki Katou Makoto Namioka Address for Service: C/- MADDERNS, GPO Box 2752, Adelaide, South Australia, Australia Invention title: METHOD OF DETECTING ALLERGEN The following statement is a full description of this invention, including the best method of performing it known to us.
DESCRIPTION TITLE OF THE INVENTION METHOD OF DETECTING ALLERGEN Technical Field [0001] The present invention relates to a method for detecting milk allergens contained in samples such as foods, using native and denatured milk allergens, native and denatured albumen allergens, native and denatured flour allergens, native and denatured buckwheat allergens or native and denatured peanut allergens as an index, and to a kit for detecting milk allergen to be used therefor. [0002] Further, the present invention relates to a method for detecting allergens that can analyze native and denatured milk allergens contained in samples such as foods, qualitatively and quantitatively with high sensitivity using asl casein which is the main protein of casein or P-lactoglobulin which is the main protein of whey as an index, and to a kit for detecting allergen to be used therefor. [0003] Moreover, the present invention relates to a method for detecting albumen allergens that can analyze albumen allergen such as native or denatured ovalbumin or ovomucoid contained in samples such as foods, qualitatively or quantitatively with high sensitivity, la using ovalbumin and/or ovomucoid as an index, and to a kit for detecting albumen allergens to be used therefor. [0004] Furthermore, the present invention relates to a method for detecting flour allergens that can analyze native and denatured flour allergens contained in samples such as foods, qualitatively or quantitatively with high sensitivity, and using gliadin which is the main protein of flour as an index and to a kit for detecting flour allergens to be used therefor. [0005] Further, the present invention relates to a method for detecting buckwheat allergens that can analyze native and denatured buckwheat allergens contained in samples such as foods, qualitatively or quantitatively with high sensitivity, and using proteins with a molecular weight of 24kDa and 76kDa which is main proteins of buckwheat as an index, and to a kit for detecting buckwheat allergens to be used therefor. [0006] Furthermore, the present invention relates to a method for detecting peanut allergens that can analyze native and denatured peanut allergen contained in samples such as foods, qualitatively or quantitatively with high sensitivity, and using Ara hl which is the main protein of peanut as an index, and to a kit for detecting peanut allergens to be used therefor. Background Art 2 [0007] Due to various factors including degradation of natural environment, gas emission from cars or industrial plants, housing conditions etc., or change of foods, it is said that one out of 3 persons suffers currently from some kind of allergic disease. Especially, food allergy is a harmful immune response induced by an intake of allergy-inducing substances (hereinafter referred to as food allergen) which induces dermatis, asthma, gastrointestinal impairment, anaphylaxis shock, etc. As the number of patients suffering such food allergy increases, severe problems are arising in the medical field, as well as in food industry. These hazards sometimes lead to death, and it is necessary to take some medical procedures in advance. Thus, necessity to provide information to consumers on a label is increasing, and the Joint FAO/WHO Food Standard Committee has agreed to indicate the content of foods containing 8 types of raw materials known as allergic substances. It was decided that each member country would consider an indication method appropriate to the system of each country (June 1999). In Japan, a labeling method was established for 24 foods, which have actually induced severe allergic symptoms, by taking into account the degree or frequency of health damage in the past (executed from April 2002). Eggs, milks, meats, fishes, shellfishes and mollusks, cereals, beans and nuts, fruits, vegetables, beer yeast, gelatin, etc. are known as foods inducing allergy. Especially, asl casein as a main ingredient of milk 3 allergen, -lactoglobulin as a main ingredient of whey allergen, ovalbumin and ovomucoid as albumen allergens, gliadin as a main ingredient of flour allergen, proteins with a molecular weight of 24kDa and 78kDa as main ingredients of buckwheat, or Arahl as a main ingredient of peanut are known. [00081 Conventionally, as methods for detecting allergens, for example, a method for quantifying immunoglobulin that reacts specifically to allergens (see Japanese Laid-Open Patent Application No. 05-249111) , a method for measuring allergen-specific IgE antibody in a sample comprising dissociating an antigen-antibody complex in the sample by acid treatment and the like, and performing neutralization treatment by using alkali according to need (Japanese Laid-Open Patent Application No. 07-140144), etc. are known. [0009] Further, as official methods (KOTEI-HO; Japan) for detecting specified raw materials such as milk, egg, flour, buckwheat, and peanut, an immunological detection method using polyclonal antibodies obtained from heated/non-heated complex antigens (see Japanese Laid-Open Patent Application No. 2003-155297; hereinafter referred to as "commercial KOTEI-HO A") , or an immunological detection method using polyclonal antibodies obtained from purified antigens (herein after referred to as "commercial KOTEI-HO B") are currently used. These methods are effective for specifically detecting 4 allergens, while they also have many problems. For example, as complex antigens are used in commercial KOTEI-HO A, it is unclear against what the antigen, and the crossing property is high. For example, antigens cannot be identified by immunoblotting, etc. and there is a possibility that non-specific responses increase. On the other hand, in commercial KOTEI-HO B, the specificity of antigens is clear as the antigens have been purified. However, as antibodies prepared by using native antigens are used, the binding-level of antibody is different depending on whether it is native or denatured, which leads to a problem that the quantitative level differs before and after heating, even when the added amount is the same. Especially, as flour is often subjected to severe heating treatment compared to other specified raw materials (eggs, milk, buckwheat, peanut), (for example, bread, fried food, etc.), flour allergens are present in a wide range, from a native state to a denatured state by heating. Therefore, it is necessary to prepare a monoclonal antibody which makes it clear to what stage of allergen the antibody is bound, and to use the antibody according to its property. [0010] Further, for identification and quantitative determination of eggs, a method using a polyclonal antibody using ovomucoid as an index (see for example, Int. Archs. Allergy appl. Immun., 75, 8-15, 1984), or a method using a monoclonal antibody (see for example, Nutr. Sci. Vitaminol. 45, 491-500, 1999) is known. Moreover, an immunological quantitative method has been reported which 5 enables identification and accurate quantitation of egg allergens by determining ovomucoid by discriminating even a denatured state by heating, with the use of a monoclonal antibody which recognizes ovomucoid, wherein the monoclonal antibody reacts with native ovomucoid while not reacting with heat-denatured ovomucoid, or that reacts with heat-denatured ovomucoid while that does not react with native ovomucoid, or that reacts with native ovomucoid and heat-denatured ovomucoid (see for example, Japanese Laid-Open Patent Application No. 2002-253230). Disclosure of the Invention [0011] The object of the present invention is to provide an immunological detection method that can detect milk allergens, albumen allergens, flour allergens, buckwheat allergens and peanut allergens in either of native or denatured state with high sensitivity, in foods containing milk allergen, albumen allergen, flour allergen, buckwheat allergen, or peanut allergen, and a detection kit to be used therein, etc. [0012] The present inventors made a keen study on a method for detecting allergens in milk, albumen, flour, buckwheat, or peanut, which are specified rawmaterials and they found out that by using 2 or more types of monoclonal antibodies recognizing native and denatured milk allergens, native and denatured albumen allergens, native and denatured flour allergens, native and denatured buckwheat allergens, 6 or native and denatured peanut allergens, allergens of each of these specified raw materials can be detected. [0013] In order to investigate a detection method of milk, which is one of the specified raw materials, as1 casein which is the main protein of casein was used as an index to produce monoclonal antibodies (hereinafter sometimes referred to as MAb) thereto, and among these, plural MAbs that can recognize native asl casein, urea-treated axsl casein, native sodium casein, and denatured sodium casein, were selected. The present inventors found out combinations of MAbs that can qualitatively and quantitatively analyze csl casein, urea-treated atsl casein, native sodium casein, and denatured sodium casein even at a concentration between 100 to 1000 ppb, by sandwich ELISA. Further, they confirmed that by using these MAbs, a person using a detection method or a detection kit of the present invention could easily detect milk allergens from test target products, regardless of how the milk allergen in food have been processed. [0014] Further, in order to investigate a detection method of milk, which is one of the specified raw materials, -lactoglobulin which is the main protein of whey was used as an index to produce monoclonal antibodies thereto, and among these, plural MAbs that can recognize native -lactoglobulin, urea-treated lactoglobulin, reduced carboxymethylated P-lactoglobulin, were selected. The present inventors found out combinations of MAbs that can 7 qualitatively and quantitatively analyze native P-lactoglobulin, urea-treated $-lactoglobulin, reduced carboxymethylated P-lactoglobulin even at a concentration between 30 to 1000 ppb. Further, they confirmed that by using these MAbs, a person using a detection method or a detection kit of the present invention could easily detect milk allergens from test target products, regardless of how the milk allergen in food have been processed. [00151 In order to investigate a detection method of albumen, which is one of the specified raw materials, monoclonal antibodies against purified ovalbumin or ovomucoid were produced, and among these, plural MAbs that can bind to native antigens and plural MAbs that can bind to denatured antigens were selected respectively. The present inventors found out that by combining a native antigen-bound MAb group and a denatured antigen-bound MAb group, ovalbumin or ovomucoid could be detected with a high sensitivity as an antigen, regardless of their condition, denatured or native. Especially, they confirmed that when a native antigen-bound MAb group and a denatured antigen-bound MAb group are used in combination, the detection can be made with a superior sensitivity compared to when a native antigen-bound MAb (group) or the denatured antigen-bound MAb (group) is used independently, even when native ovalbumin or ovomucoid, or denatured ovalbumin or ovomucoid is present alone. Further, they confirmed that by combining MAbs against ovalbumin and ovomucoid which are albumen allergens, a person using a detection method 8 or a detection kit of the present invention could easily detect albumen allergens, regardless of how the albumen allergen in food have been processed. [0016] In order to investigate a detection method of flour, which is one of the specified raw materials, monoclonal antibodies against purified gliadin were produced, and plural MAbs that can recognize native flour gliadin, reduced carboxymethylated flour gliadin, and flour gliadin solubilized with 0.1 M acetate, flour gliadin solubilized with 70% ethanol, flour gliadin solubilized with a denaturant were selected. The present inventors found out combinations of MAbs that can qualitatively and quantitatively analyze native flour gliadin, reduced carboxymethylated flour gliadin, flour gliadin solubilized with 0.1 M acetate, flour gliadin solubilized with 70% ethanol, and flour gliadin solubilized with a denaturant, even at a concentration between 10 to 100 ppb, by sandwich ELISA. Further, they confirmed that by using these MAbs, a person using a detection method or a detection kit of the present invention could easily detect flour allergen from test target products, regardless of how the flour allergen in food have been processed. [0017] In order to investigate a detection method of buckwheat, which is one of the specified raw materials, monoclonal antibodies against purified 24 kDa-protein, or purified 76 kDa-protein were produced, and among these, plural MAbs that can recognize 24kDa-protein or 76 9 kDa-protein were selected. The present inventors found out, combinations of MAbs bondable to native buckwheat protein with MAbs bondable to denatured buckwheat protein that can analyze buckwheat proteins with a high sensitivity, regardless of their state, that is whether it is non-heated (native) or heated (denatured) by sandwich ELISA. Further, they confirmed that by using these MAbs, regardless of how the buckwheat allergen in food have been processed, a person using a detection method or a detection kit of the present invention could easily detect buckwheat allergens from test target products. [0018] In order to investigate a detection method of peanut, which is one of the specified raw materials, monoclonal antibodies against purified native Ara hl (hereinafter sometimes referred to as "NAhl"), or denatured Ara hl (hereinafter sometimes referred to as "DAhl"), which is a purified Ara hl that has been denatured with urea and m12-mercaptoethanol, were produced. Among these, plural MAbs that can recognize Nahl, DAhl, native peanut-crude protein (hereinafter sometimes re-ferred to as "NP-e"), and/or urea-treated peanut-crude protein (hereinafter sometimes referred to as "DP-e") were selected. The present inventors found out, a combination of MAbs that can analyze peanut protein with a high sensitivity regardless of its state, that is whether it is (non-heated) native, or heated (denatured) by sandwich ELISA. Further, they confirmed that by using these MAbs, a person using a detection method or a detection kit of the present 10 invention could easily detect peanut allergen from test target products, regardless of how the peanut allergen in food have been processed. Brief Description of the Drawings [0019] [Fig. 11 It is a figure that shows the results of sandwich ELISA to asl caseins at various states by using 2 types of anti-asl casein MAbs of the present invention (milk allergen). [Fig. 2] It is a figure that shows the difference of component protein of flour-asl casein that is recognized by PasICN1 and Pas1CN2 of the present invention (milk allergen). [Fig. 3] It is a figure that shows the reactivity of PLG2 and PLG1 against various P-lactoglobulins by sandwich ELISA of the present invention (milk allergen). [Fig. 4] It is a figure that shows the reactivity of PLG2 and PLG3 against various P-lactoglobulins by sandwich ELISA of the present invention (milk allergen). [Fig. 5] It is a figure that shows the reactivity against native lactoglobulins in a MAb-mixed system by sandwich ELISA of the present invention (milk allergen). [Fig. 6] It is a figure that shows the reactivity against 11 urea-treated lactoglobulins in a MAb-mixed system by sandwich ELISA of the present invention (milk allergen) [Fig. 7] It is a figure that shows the reactivity of anti-ovalbumin MAbs against each serial dilution in Test 1 of the present invention (albumen allergen). [Fig. 8] It is a figure that shows the reactivity of anti-ovalbumin MAbs against each serial dilution in Test 2 of the present invention (albumen allergen). [Fig. 9] It is a figure that shows the reactivity of anti-ovalbumin MAbs against each serial dilution in Test 3 of the present invention (albumen allergen). [Fig. 10] It is a figure that shows the reactivity of PNOM1 and PNOM2 against denatured/native ovomucoid by sandwich ELISA of the present invention (albumen allergen). [Fig. 11] It is a figure that shows the reactivity of PDOM1 and PDOM2 against denatured/native ovomucoid by sandwich ELISA of the present invention (albumen allergen). [Fig. 12] It is a figure that shows the reactivity of PDOM2 and PDOM2, and PNOM1 and PDOM1 against denatured/native ovomucoid by sandwich ELISA of the present invention (albumen allergen). [Fig. 13] It is a figure that shows the results of sandwich 12 ELISA against gliadin in various states, using 2 types of anti-gliadin MAbs of the present invention (flour allergen). [Fig. 14] It is a figure that shows the difference of constitutive protein of flour gliadin recognized by PGLl and PGL2 of the present invention (flour allergen). [Fig. 15] It is a figure that shows the reactivity of PBW2 and PBW3 against various buckwheat crude proteins by sandwich ELISA of the present invention (buckwheat allergen). [Fig. 16] It is a figure that shows the reactivity of PBWl and PBW2 against various buckwheat crude proteins by sandwich ELISA of the present invention (buckwheat allergen). [Fig. 17] It is a figure that shows the reactivity of MAb-mixed system of PBW1, PBW2 and PBW3 against native buckwheat crude proteins by sandwich ELISA of the present invention (buckwheat allergen). [Fig. 18] It is a figure that shows the reactivity of MAb-mixed system of PBW1, PBW2 and PBW3 against denatured buckwheat crude proteins by sandwich ELISA of the present invention (buckwheat allergen). [Fig. 19] It is a figure that shows the reactivity of PAh1-1 and PAhl-2 against various peanut crude proteins by sandwich ELISAof the present invention (peanut allergen). 13 [Fig. 201 It is a figure that shows the reactivity of PAhl-2 and PAhl-3 against various peanut crude proteins by sandwich ELISAof the present invention (peanut allergen). 5 [Fig. 21] It is a figure that shows the reactivity of MAb-mixed system of PAhl-l, PAhl-2 and PAhl-3 against native peanut crude proteins by sandwich ELISA of the present invention (peanut allergen). 10 [Fig. 22] It is a figure that shows the reactivity of MAb-mixed system of PAhl-1, PAhl-2 and PAhl-3 against denatured peanut crude proteins by sandwich ELISA of the present invention (peanut allergen). 15 Best Mode of Carrying out the Invention [0020] Methods for detecting allergens contained in foods of the present invention are not particularly limited as 20 long as it is a method for detecting allergens by using 2 or more types of monoclonal antibodies recognizing native and denatured milk allergens, native and denatured albumen allergens, native and denatured flour allergens, native and denatured buckwheat allergens, or native and 25 denatured peanut allergens, using asl casein which is the main protein of milk casein, 5-lactoglobulin which is the main protein of whey, ovalbumin and ovomucoid which are main proteins of albumin, gliadin which is the main protein of flour, proteins with a molecular weight of 24kDa and 14 76kDa which are main proteins of buckwheat, or Ara hl which is the main protein of peanut, as an index. [0021] Methods for detecting milk allergens of the present invention are not particularly limited as long as it is an immunological method for detecting milk allergens using monoclonal antibodies recognizing native milk allergens and monoclonal antibodies recognizing denatured milk allergens simultaneously. Further, kits for detecting milk allergens of the present invention are not particularly limited as long as it is an immunological kit for detecting allergens, comprising a monoclonal antibody recognizing native milk allergens and a monoclonal antibody recognizing denatured milk allergens, and used under the condition of using a monoclonal antibody recognizing native milk allergens and a monoclonal antibody recognizing denatured milk allergens are used in combination. However, it is preferable that a kit comprises 2 or more monoclonal antibodies recognizing different epitopes respectively, as monoclonal antibodies recognizing native milk allergens and/or denatured milk allergens. As such monoclonal antibodies recognizing native milk allergens and/or denatured milk allergens, anti-casl casein monoclonal antibodies and anti--lactoglobulin monoclonal antibodies can be specifically exemplified. "Milk allergens" herein mentioned relates to those comprising axsl casein which is the main protein of milk casein and/or -lactoglobulin which is the main protein of whey. 15 (0022] Examples of the above anti-axsl casein monoclonal antibodies include anti casl-casein monoclonal antibodies recognizing native axsl casein, urea-treated asl casein, native sodium casein and denatured sodium casein. Specifically, monoclonal antibodies recognizing the 132 - 193 position of the amino acid sequence of casl casein shown by SEQ ID NO: 1 can be preferably exemplified. Specifically, the anti-axsl casein monoclonal antibody PaslCNl produced by hybridoma (FERM ABP-10263), the anti-asl casein monoclonal antibody PaslCN2 produced by hybridoma (FERM ABP-10264) etc. can be preferably exemplified. Moreover, by combining PaslCN1 and PaslCN2, sandwich ELISA and immunochromatography can be performed more advantageously. For example, by using these monoclonal antibodies, native axsl casein and urea-treated csl casein in foods can be analyzed qualitatively and quantitatively even at a concentration between 10 to 1000 ppb, by sandwich ELISA. [0023] Examples of the above anti-J-lactoglobulin monoclonal antibody include anti--lactoglobulin monoclonal antibodies recognizing native 0-lactoglobulin, urea-treated P-lactoglobulin, and reduced carboxymethylated -lactoglobulin. Specifically, the anti-P-lactoglobulin monoclonal antibody PLGlproduced by hybridoma (FERM ABP-10281) and the anti -lactoglobulin monoclonal antibody PLG2 produced by hybridoma (FERM ABP-10282) , the anti -lactoglobulin monoclonal antibody 16 PLG3 produced by hybridoma (FERM ABP-10283) , etc. can be preferably exemplified. Further, by combining PLG2 and PLG1, PLG2 and PLG3, PLG2, PLG1 and PLG3, sandwich ELISA and immunochromatography can be performed more advantageously. For example, by using these antibodies, native P-lactoglobulin and urea-treated P-lactoglobulin in foods can be analyzed qualitatively and quantitatively even at a concentration between 30 to 1000 ppb, by sandwich ELISA. [0024] In a method for detecting milk allergens of the present invention, it is preferable to extract casein and/or whey protein from a sample by using urea and 2-mercaptoethanol. Moreover, it is preferable to use 1 or more monoclonal antibodies recognizing a native casein and 1 or more monoclonal antibodies recognizing a denatured casein, and 1 or more monoclonal antibodies recognizing a native P-lactoglobulin and 1 or more monoclonal antibodies recognizing a denatured -lactoglobulin. Moreover, in a kit for detecting milk allergens of the present invention, a kit comprising urea and 2-mercaptoehtanol to extract casein and/or whey protein is preferable, and a kit comprising 1 or more monoclonal antibodies recognizing a native casein and 1 or more monoclonal antibodies recognizing a denatured casein, and 1 or more monoclonal antibodies recognizing a native P-lactoglobulin and 1 or more monoclonal antibodies recognizing a denatured P-lactoglobulin, are preferable. 17 [0025] Methods for detecting albumen allergens of the present invention are not particularly limited as long as it is an immunological method for detecting albumen allergens using monoclonal antibodies recognizing native albumen allergens and monoclonal antibodies recognizing denatured albumen allergens simultaneously. Further, kits for detecting albumen allergens of the present invention are not particularly limited as long as it is an immunological kit for detecting allergens, comprising monoclonal antibodies recognizing native albumen allergens and monoclonal antibodies recognizing denatured albumen allergens, and used under a condition where a monoclonal antibody recognizing native albumen allergens and a monoclonal antibody recognizing denatured albumen allergens simultaneously. However, it is preferable to comprise 2 or more monoclonal antibodies recognizing different epitopes respectively, as monoclonal antibodies recognizing native albumen allergens and/or denatured albumen allergens. As such monoclonal antibodies recognizing native albumen allergens and/or denatured albumen allergens, anti-ovalbumin monoclonal antibodies and anti-ovomucoid monoclonal antibodies can be specifically exemplified. "Albumen allergens" herein mentioned relates to those comprising ovalbumin and/or ovomucoid which are main proteins of albumen. [0026] As the above anti-ovalbumin monoclonal antibodies, anti-ovalbumin monoclonal antibodies recognizing a native 18 ovalbumin and/or a reduced carboxymethylated ovalbumin are preferable. Specifically, the anti-ovalbumin monoclonal antibody PNOAl produced by hybridoma (FERM ABP-10265) , the anti-ovalbumin monoclonal antibody PNOA2 produced by hybridoma (FERMABP-10266), the anti ovalbumin monoclonal antibody PDOAl produced by hybridoma (FERM ABP-10275) , the anti ovalbumin monoclonal antibody PDOA2 produced by hybridoma (FERM ABP-10276) etc. can be preferably exemplified. Further, by using the combination of anti-native ovalbumin monoclonal antibodies such as PNOAl and PNOA2, and anti denatured ovalbumin monoclonal antibodies such as PDOA1 and PDOA2, or especially by combining anti-native ovalbumin monoclonal antibodies such as PNOA1 and PNOA2 with anti-native ovalbumin monoclonal antibodies such as PDOAl and PDOA2, sandwich ELISA or immunochromatography can be performed more advantageously. For example, by using these antibodies, native ovalbumin and/or denatured ovalbumin in foods can be analyzed qualitatively and quantitatively even at a concentration between 1.0 to 10.0 ppb by sandwich ELISA. [0027] As the above anti-ovomucoid monoclonal antibodies, anti ovomuccid monoclonal antibodies recognizing a native ovomucoid and/or an urea denatured-ovomucoid can be exemplified. Specifically, the anti-ovomucoid monoclonal antibody PNOM1 produced by hybridoma (FERM ABP-10279), the anti-ovomucoid monoclonal antibody PNOM2 produced by hybridoma (FERM ABP-10280), the 19 anti-ovomucoid monoclonal antibody PDOM1 produced by hybridoma (FERMABP-10277), the anti-ovomucoidmonoclonal antibody PDOM2 produced by hybridoma (FERM ABP-10278) , etc. can be preferably exemplified. Further, by using the combination of anti-native ovomucoid monoclonal antibodies such as PNOM1 and PNOM2, and anti-denatured ovomucoid monoclonal antibodies such as PDOM1 and PDOM2, especially by combining anti-native ovomucoid monoclonal antibodies such as PNOM1 and PNOM2 with anti-denatured ovomucoid monoclonal antibodies such as PDOM1 and PDOM2, sandwich ELISA and immunochromatography can be performed more advantageously. For example, by using these antibodies, native ovomucoid and/or denatured ovomucoid in foods can be analyzed qualitatively and quantitatively even at a concentration between 10 to 100 ppb by sandwich ELISA. [0028] In a method for detecting albumen allergens of the present invention, it is preferable to extract ovalbumin and/or ovomucoid by using urea and 2-mercaptoethanol. Further, it is preferable to use 1 or more monoclonal antibodies recognizing a native ovalbumin and 1 or more monoclonal antibodies recognizing a denatured ovalbumin, and 1 or more monoclonal antibodies recognizing a native ovomucoid and 1 or more monoclonal antibodies recognizing a denatured ovomucoid. Further, for kits for detecting albumen allergens of the present invention, those comprising urea and 2-mercaptomethanol for extracting ovalbumin and/or ovomucoid are preferable, and those 20 comprising 1 or more monoclonal antibodies recognizing a native ovalbumin and 1 or more monoclonal antibodies recognizing a denatured ovalbumin, and 1 or more monoclonal antibodies recognizing a native ovomucoid and 1 or more monoclonal antibodies recognizing a denatured ovomucoid are preferable. [0029] Methods for detecting flour allergens of the present invention are not particularly limited as long as it is an immunological method for detecting flour allergens by using anti-flour gliadin monoclonal antibodies recognizing native a flour gliadin and a flour gliadin solubilized with a denaturant; or an immunological method for detecting flour allergen using in combination 2 types of anti-flour gliadin monoclonal antibodies recognizing a native flour gliadin and a flour gliadin solubilized with a denaturant, and recognizing different epitopes. Further, kits for detecting flour allergens of the present invention are not particularly limited as long as it is an immunological kit for detecting allergens comprising anti-flour gliadin monoclonal antibodies recognizing a native flour gliadin and a flour gliadin solubulized with a denaturant, or an immunological kit for detecting allergen comprising 2 types of anti flour gliadine monoclonal antibodies recognizing a native flour gliadin and a flour gliadin solubilized with a denaturant, and recognizing different epitopes. As the above anti- flour gliadin monoclonal antibodies, anti-flour gliadin monoclonal antibodies recognizing a native flour gliadin, 21 a reduced carboxymethylated flour gliadin, a flour gliadin solubilized with 0.1 M acetate, a flour gliadin solubilized with 70% ethanol, and a flour gliadin solubilized with a denaturant are preferable. Specifically, the anti-flour gliadin antibody PGL1 produced by hybridoma (FERM BP-10267) and the anti-flour gliadin antibody PGL2 produced by hybridoma (FERM BP-10268) can be preferably exemplified. By combining these antibodies, sandwich ELISA or immunochromatography can be performed more advantageously. For example, it is possible to analyze qualitatively and quantitatively native flour gliadin, reduced-carboxymethylated flour gliadin, flour gliadin solubilized with 0.1 M acetate, flour gliadin solubilized with 70% ethanol, and flour gliadin solubilized with a denaturant in foods, even at a concentration between 10 to 100 ppb. [0030] Methods for detecting buckwheat allergens of the present invention are not particularly limited as long as it is an immunological method for detecting buckwheat allergens using anti-buckwheat crude protein monoclonal antibodies recognizing a native buckwheat crude protein and a heat-denatured buckwheat crude protein; or an immunological method for detecting buckwheat allergens using 2 types of anti-buckwheat crude protein monoclonal antibodies recognizing a native buckwheat crude protein and a heat-denatured buckwheat crude protein, and recognizing different epitopes. Further, kits for detecting buckwheat allergens of the present invention are 22 not particularly limited as long as it is an immunological kit for detecting allergens comprising anti-buckwheat crude protein monoclonal antibodies recognizing a native buckwheat crude protein and a heat-denatured buckwheat crude protein, or an immunological kit for detecting allergens comprising 2 types of anti-buckwheat crude protein antibodies recognizing a native buckwheat crude protein and a heat-denatured buckwheat crude protein, and recognizing different epitopes. As anti-buckwheat crude protein monoclonal antibodies, anti-buckwheat crude protein monoclonal antibodies recognizing a 24 kDa-protein and a heat-denatured buckwheat crude protein, or anti-buckwheat crude protein monoclonal antibodies recognizing a 76kDa-protein and a native buckwheat crude protein are preferable. Specifically, the anti-24kDa protein monoclonal antibody PBW1 produced by hybridoma (FERM ABP-10272), the anti-76kDa-protein monoclonal antibody PBW2 produced by hybridoma (FERM ABP-10273) , the anti-76kDa protein monoclonal antibody PBW3 produced by hybridoma (FERM ABP-10274) can be preferably exemplified. Further, the combination of anti-buckwheat crude protein monoclonal antibodies recognizing a 24kDa-protein such as PBW1 and heat-denatured buckwheat crude proteins with anti-buckwheat crude protein monoclonal antibodies recognizing a 76kDa-protein such as PBW2 and native buckwheat crude proteins; or the combination of anti-buckwheat crude protein monoclonal antibodies recognizing a native buckwheat crude protein such as PBW2 and PBW 3, and a heat-denatured buckwheat crude protein 23 can be preferably exemplified. Further, by combining these antibodies as a mixed system, sandwich ELISA and immunochromatography can be performed more advantageously. For example, native buckwheat crude proteins and heat-denatured crude proteins can be analyzed qualitatively and quantitatively even at a concentration between 10 to 1000 ppb by sandwich ELISA. [0031] Further, in a method of detecting buckwheat allergens of the present invention, it is preferable to extract heat-denatured buckwheat crude proteins by using urea and 2-mercaptoethanol from a sample. Further, as kits for detecting buckwheat allergens of the present invention, those comprising urea and 2-mercaptoehtanol as an agent for extracting buckwheat crude proteins from a sample are preferable. [0032] Methods for detecting peanut allergens of the present invention are not particularly limited as long as it is an immunological method for detecting peanut allergens using anti-Ara hl protein monoclonal antibodies recognizing a native peanut Ara hl protein and a heat-denatured peanut Ara hl protein, or an immunological method for detecting peanut allergens using 2 types of anti-Ara hl protein monoclonal antibodies recognizing a native peanut Ara hl protein and a heat-denatured peanut Ara hl protein, and recognizing different epitopes. Further, kits for detecting peanut allergens of the present invention are not particularly limited as long as 24 it is an immunological kit for detecting allergens comprising anti-peanut Ara hl protein monoclonal antibodies recognizing a native peanut Ara hi protein and a heat-denatured peanut Ara hl protein, or an immunological kit for detecting allergens comprising 2 types of anti-peanut Ara hl protein monoclonal antibodies recognizing a native peanut Ara hl protein and a heat-denatured peanut Ara hl protein, and recognizing different epitopes. As anti-Ara hl protein monoclonal antibodies, anti-Ara hl protein monoclonal antibodies recognizing a native Ara hl protein and a native peanut crude proteins and/or urea-treated Ara hl proteins and urea-treated peanut crude proteins are preferable. Specifically, the anti-native Ara hl protein monoclonal antibody PAhl-1 produced by hybridoma (FERM ABP-10269), the anti-native Ara hl protein monoclonal antibody PAhl-2 produced by hybridoma (FERM ABP-10270), the anti-heat-denatured Ara hl protein monoclonal antibody PAhl-3 produced by hybridoma (FERM ABP-10271) can be preferably exemplified. Further, by using the combination of anti-Ara hl protein monoclonal antibodies recognizing native a Ara hl protein such as PAhI-1 and a denatured peanut crude proteins, and anti-Ara hl protein monoclonal antibodies recognizing a native/denatured Ara hl protein such as PAhl-2 and a native/denatured peanut crude proteins, or the combination of anti-Ara hl protein monoclonal antibodies each recognizing a native/denatured Ara hl protein such as PAhl-2 and PAhl-3, and a native/denatured peanut crude protein, and further by 25 combining these antibodies as a mixed system, sandwich ELISA and immunochromatography can be performed more advantageously. For example, native peanut Ara hl proteins and heat-denatured peanut Ara hl proteins can be analyzed qualitatively and quantitatively even at a concentration between 10 to 1000 ppb, by sandwich ELISA. [0033] Moreover, in a method for detecting peanut allergens of the present invention, it is preferable to extract heat-denatured peanut crude protein from a sample by using urea and 2-mercaptoethanol. Further, as kits for detecting peanut allergens of the present invention, those comprising urea and 2-mercaptoehtanol as agents for extracting heat-denatured peanut crude proteins from a sample are preferable. [0034] The above immunological methods for detecting allergen of the present invention comprise the following steps: an immune reaction step wherein a sample comprising native/denatured milk allergens, native/denatured albumen allergens, native/denatured flour allergens, native/denatured buckwheat allergens or native/denatured peanut allergens (hereinafter sometimes referred to as "food allergens") is allowed to contact a labeled anti-food allergen MAb, or to contact a food allergen MAb in the presence of a labeled antibody, and to trap as a labeled immune complex by an antigen-antibody reaction; and a detection step wherein the generated immune complex is separated/measured by using labeled substances which 26 are present in the molecule. Methods of antigen-antibody reaction in the immune response step are not particularly limited, and the following can be exemplified. [0035] The examples include: a sandwich method wherein a food allergen in a sample is trapped to an anti-food allergen MAb of the present invention bound to an insolubilized carrier, and then allowed to react a labeled anti-IgG antibody; a double-antibody sandwich method using a labeled anti-food allergen MAb (secondary antibody) recognizing an epitope different from an anti-food allergen MAb bound to an insolubilized carrier; a competitive method wherein a food allergen in a sample is allowed to react with an anti-food allergen MAb bound to an insolubilzed carrier in the presence of a labeled antigen; a magnetic bead method wherein a magnetic bead-bound labeled anti food allergen MAb reacting specifically with a sample containing a food allergen is allowed to react with the sample, and then a labeled substance in an immune complex separated magnetically is detected; an agglutination-precipitation method wherein a labeled anti-food allergen MAb reacting specifically with a sample containing a food allergen is allowed to react with the sample, and to agglutinate and precipitate, and then a labeled substance in an immune complex separated by centrifugation is detected; an immunochromatology method wherein an anti-food allergic protein MAb binding to a food allergen is fixed in advance on the test strip where an antigen-antibody complex, in which an anti-food 27 allergen MAb labeled with such as gold colloid and a food allergenic protein are bound, moves by a capillary phenomenon etc., and a qualitative analyze is performed according to the presence or absence of a colored line appearing by trapping the antigen-antibody complex. Besides these examples, known immunoassays including a double immunodiffusion method or a radicimmunodif fusion method can be used. However, a method using 2 or more monoclonal antibodies recognizing different epitopes, as food allergen antibodies, for example a double-antibody sandwich method that can analyze qualitatively and quantitatively native allergens and/or denatured allergens even at a concentration between 100 to 1000 ppb, is preferable for its high sensitivity, or an immunochromatography method is preferable qualitatively from the point of its easiness. Further, when extracting allergen from a food sample such as meat products, it is preferable to use urea and 2-mercaptoethanol. [0036] As insolubilized carriers used in the above antigen-antibody reactions, polymers including polystyrene, polyethylene, polypropylene, polyester, polyacrylonitrile, fluorine resin, crosslinking dextran, polysaccharide, as well as glass, metal, magnetic particles and combinations thereof can be exemplified. The form of insolubilized carriers can be for example, a form of tray, sphere, fiber, bar, disk, container, cell, microplate, test tube or latex bead, and various forms can be used. Further, methods for fixing antigens or 28 antibodies to these insolubilized carriers are not particularly limited, and physical absorption method, covalent binding method, ion binding method and the like can be used. [0037] Classes and types of immune globulin of anti-food allergen MAbs used in a method for detecting food allergens or in a kit for detecting food allergens of the present invention are not particularly limited, while antibodies of IgG class or type K are preferably used as anti-food allergen MAbs. Further, as configuration of monoclonal antibodies, a full antibody, and fragments including F (ab' )2, or Fab can be used. Origins of antibodies are not particularly limited, and examples include mouse, rat, human, rabbit and chicken. However, monoclonal antibodies derived from a mouse are preferably used as it is easy to prepare. Further, anti-food allergen MAbs can be prepared by culturing hybridomas prepared by cell fusion of antibody-producing cells collected from animals immunized with native or denatured casl casein and myeloma cells in a medium, or by administering the hybridomas in an animal intraperitonally and proliferating the same, and then collecting from the culture or the ascetic fluid. [0038] Anti-food allergen MAb-producing hybridomas can be produced by, for example, immunizing a BALB/c mouse by using native and/or denatured food allergens, performing cell fusion of antibody-producing cells of the immunized mouse and mouse myleloma cells by common methods, and 29 screening by immunofluorescent staining patterns. The above antibody-producing cells include, for example, spleen cells, lymph node cells and B-lymphocytes obtained from immunized animals that have been administered with native and/or denatured food allergens or a composition containing the same. As animals to immunize, mice, rats, rabbits and horses can be exemplified. Immunization is performed by, for example, administering native and/or food allergens directly or with an appropriate adjuvant to an animal, subcutaneously, intramuscularly or intraperitoneally, 1 or 2 times per month, for 1 to 6 months. Separation of antibody-producing cells is performed by collecting from the immunized animals, 2 to 4 days after the final immunization. As myeloma cells, those derived from mice or rats can be used. It is preferable that antibody-producing cells and myeloma cells are from the animals of the same species. [0039] Cell fusion can be performed by mixing antibody-producing cells and myeloma cells in a medium such as Dulbecco's modified Eagle medium (DMEM), in the presence of fusion promoters such as polyethylene glycol. After the cell fusion, hybridomas are selected by diluting appropriately with DMEM etc., centrifuging, and suspending the precipitates in a selective medium such as HAT medium, and culturing the same. Subsequently, antibody-producing hybridomas are searched by enzymatic-antibody method with the use of a culture supernatant, cloned by a limiting dilution method, etc. 30 to obtain hybridomas producing anti-food allergen MAbs. Further, anti-denatured food allergen MAbs can also be obtained advantageously from anti-immunized animals immunized with only native food allergens such as asl casein. In that case, anti-denatured food allergen MAb-producing hybridomas such as anti-denatured asl casein MAbs can be screened; or monoclonal antibody-producing hybridomas against native food allergens such as native asl casein can be selected by ELISA at a solid-phase condition, to obtain anti-food allergen MAbs which only react specifically to native food allergens in liquid-phase condition from the monoclonal antibodies generated from the antibody-producing hybridomas. As described above, monoclonal antibodies can be collected from cultures after culturing antibody-producing hybridomas in a medium or in vivo. Methods for separating/purifying monoclonal antibodies from the cultures or the ascetic fluid are not particularly limited as long as it is a method generally used for protein purification. For example, it can be performed by ammonium sulfate fractionation method generally used for IgG puri fication, or by chromatography by anion exchange, or columns such as protein A and G. [0040] Labeled substances used for labeled antibody preparation are not particularly limited as long as it is a labeled substance that can induce a signal which can be detected alone or by reacting with other substances. Enzymes, fluorescent substances, chemical 31 photosubstances, radioactive substances and gold colloids can be used. Enzymes include peroxidase, alkaline phosphatase, P-D-galactosidase, glucose oxydase, glucose-6-phophate dehydrogenase, alcohol dehydrogenase, malate dehydrogenase, penicillinase, catalase, apoglucose oxidase, urease, luciferase or acetyl cholinesterase. Fluorescent substances include fluorsecine isothiocyanate, phycobiliprotein, rare-earth metal chilate, dansylchloride or tetramethylrodamine isothiocyanate. Photosubstances include luminols, dioxetanes, acridinium salts. Radioactive substances include 3 H, 1 4 C, 1251 or 1I3. When a labeled substance is an enzyme, substrates can be used to measure its activity as well as coloring agents, fluorescent agents, radioagents, according to need. [0041] Kits for measuring food allergens of the present invention comprises anti-food allergen MAbs as active ingredients, preferably 2 or more types of anti-food allergen MAbs recognizing different epitopes, which are stored preferably as a lyophilizate than in a fluid condition, from the point of view of storage stability. Kits for detection may comprise buffer solution and the like for preparing a sample, besides buffer solution or culture solution to solubilize anti-food allergen MAbs. Further, as a more preferable embodiment of a kit for detecting anti-food allergens of the present invention, test strips of the above immunochromatography can be exemplified. In that case, at least one of the 2 types 32 of monoclonal antibodies recognizing different epitopes is preferably a monoclonal antibody labeled with gold colloid used in the immunochromatography. [0042] Monoclonal antibodies of the present invention include: anti-xsl casein monoclonal antibody Pas1CN1 generated by hybridoma (FERM ABP-10263); anti-asl casein monoclonal antibody Pas1CN2 generated by hybridoma (FERM ABP-10264); anti-p-lactoglobulin monoclonal antibody PLG1 generated by hybridoma (FERM ABP-10281); anti-p-lactoglobulin monoclonal antibody PLG2 generated by hybridoma (FERM ABP-10282); anti-3 lactoglobulin monoclonal antibody PLG3 generated by hybridoma (FERM ABP-10283); anti-ovalbumin monoclonal antibody PNOA1 generated by hybridoma (FERM ABP-10265); anti-ovalbumin monoclonal antibody PNOA2 generated by hybridoma (FERM ABP 10266); anti-ovalbumin monoclonal antibody PDOA1 generated by hybridoma (FERM ABP-10275) ; anti-ovalbumin monoclonal antibody PDOA2 generated by hybridoma (FERM ABP-10276) ; anti-ovomucoid monoclonal antibody PNOM1 generated by hybridoma (FERM ABP 10279); anti-ovomucoid monoclonal antibody PNOM2 generated by hybridoma (FERM ABP-10280) ; anti-ovomucoid monoclonal antibody PDOM1 generated by hybridoma (FERM ABP-10277) ; anti-ovomucoid monoclonal antibody PDOM2 generated by hybridoma (FERM ABP 10278); anti-flour gliadin monoclonal antibody PGL1 generated by hybridoma (FERM BP-10267); anti-flour gliadin monoclonal antibody PGL2 generated by hybridoma (FERM BP-10268) ; anti 24kDa protein monoclonal antibody PBWl generated by hybridoma (FERM ABP-10272) ; anti-76kDa protein monoclonal antibody PBW2 generated by hybridoma (FERM ABP-10273) ; anti-76kDa protein monoclonal antibody PBW3 generated by hybridoma (FERM ABP-10274); anti-native Ara hl protein monoclonal antibody PAhl-l generated by hybridoma (FERM ABP-10269); anti-native Ara hl protein monoclonal antibody PAhl-2 generated by hybridoma (FERM ABP-10270); and anti-heat-denatured Ara hl protein monoclonal antibody PAhl-3 generated by hybridoma (FERM ABP-10271). These hybridomas have been accepted at National Institute of Advanced Industrial Science and Technology, International Patent Organism Depositary (Central 6, 1-1, Higashi 1-chome Tsukuba-shi, Ibaraki-ken 305-5466, Japan) on February 24, 2005 (date of receipt). Meanwhile, the above-mentioned PaslCN1 (FERM P-20206), PaslCN2 (FERM P-20207) , PNOAl (FERM P-20208) , PNOA2 (FERM P-20209, PGL1 (FERMP-20210) , PGL2 (FERM P-20211) are those deposited at National Institute of Advanced Industrial Science and Technology, International Patent Organism Depositary, on September 7, 2004 (date of deposit). [0043] In the following, the present invention is explained in more detail by referring to the Examples, while the technical scope of the present invention is not limited to these exemplifications. Example 1 [0044] 1. Establishment of anti-asl casein monoclonal antibodies 34 1-1 Materials and methods 1) Preparation of axsl casein (hereinafter referred to as "aCN ") Crude fractions of aCN were obtained from fresh milk, according to Zittle (1959). The crude fractions were further purified by using TSK gel DEAE 650S (TOSOH) with a linear gradient (0 to 0.3 M) of NaCl containing 50 mM of imidazole-HCl buffer solution (pH 6.4) and 4M of urea. The purified aCN fraction was dialyzed with distilled water and then lyophilized. A 0.1% solution of the lyophilizates was prepared with saline, which was aliquoted in 1 ml-volume Eppendorf tubes at 500 [l per tube, stored by freezing at -20 0 C until immunization, and the resultant was used as an antigen solution. [0045) 2) Immunization As test animals, 5 BALB/c mice (CLEA Japan) of 6 weeks-old were used. For the primary immunization, an emulsion, prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 pl of 0.1% ciCN at an equal amount, and stirring in a vortex mixer, was used. The emulsion was injected intraperitoneally in an amount of 150 ptl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to each Eppendorf tube filled with 500 pl of 0.1% cxCN at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pl per 35 mouse. [00461 3) Measurement of antibody titer in blood One week after injecting acCN as the primary or additional immunization, blood was collected from tail vein ofeach BALB/cmouse. The blood collected was allowed to stand for 2 hours at room temperature, and centrifuged to obtain serum. 10-fold serial dilution of these sera was prepared, and the anti- aCN antibody titer in the mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0047] 2) Preparation of hybridomas Hybridomas were prepared according to the methods of Keller and Milstein (1975) . In other words, 100 ptl of 0.1% ctCN solution was injected into tail vein of a mouse whose antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after the intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 36 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3,350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective medium consisting of a hybridoma medium (RPMIl640 medium containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) and 100 pLM of hypoxanthine, 0.4 pM of aminopterin and 16 pM of thymidine was added the palette. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 37'C, in the presence of 5% C02. [0048] 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies for ELISA and producing anti-aCN antibodies was examined for the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against ctCN by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 media containing 10% of bovine fetal serum, 40 mM 2-mercaptoethanol, 100 U/ml of penicillin, 100 [tg/ml of streptomycin were used for culturing cloned hybridomas. [0049] 6) Screening of antibodies 37 By screening monoclonal antibodies, clones having different specificities were obtained by examining the difference of reactivity against 4 types of proteins, that is, native aCN (hereinafter referred to as "N-aCN"), urea-treated aCN (hereinafter referred to as "D-aCN"), commercial native substances of sodium casein (hereinafter referred to as "N-CN"), and commercial urea-treated substances of sodium casein (hereinafter referred to as "D-CN") . D-aCN was denatured by the following steps: 1 mg of purified cCN was measured, 100 pil of 5% EDTA, 6.0 g of urea, 0.2 ml 2-mercaptoethanol, 1 ml 50 mM tris-hydrochloric buffer solution (pH 8.6) , 1.5 ml distilled water were added to the cxCN. The resultant was covered with an aluminum cap, and heated at 100*C for 1 hour in an oil bath. The reactivity against N-aCN, D-aCN, N-CN or D-CN of the culture supernatant was examined by non-competitive ELISA. [0050] 7) Collection of ascitic fluid and purification of MAbs According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/well of cloned hybridomas were inoculated per mouse. After accumulation of ascitic fluid, the fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [0051] 8) Classes, subclasses and types of MAbs Classes and subclasses of MAbs were determined 38 according to Monoclonal mouse immuno aCNobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y). [0052] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. The biotinylated MAb was added with 10 pl of NHS-biotin solution which was prepared with 50 mM of carbonate buffer solution (pH 8.5) to 20 mg/ml and dissolved in DMSO at 3 mg/100 tl. The mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS to 20 mg/ml. [0053] 1-2 Results 1) Selection of MAbs 6 types of MAbs recognizing specifically asl casein (aCN) which is a main allergen of milk were obtained. The specificity of these 6 types of MAbs against each antigen, N- ctCN, D- xCN, N-CN or D-CN which has been solid-phased was examined by direct ELISA. Further, classes and subclasses of these MAbs were investigated as well. The results are shown in Table 1. In Table 1, "+" represents that MAbs are positive against each solid-phased antigen, and "-" represents that MAbs are negative. As it is shown in Table 1, PaslCN1, PaslCN2, PaslCN3 which are MAbs binding to antigens in every state were selected. [0054] [Table 1] MAbs N - aC N D- aC N N - C N D - C N Classes, subclasses - and Types 39 Pas1CN1 + + + + IgG1 ( K) Pas1CN2 + + + + IgG1(K) Pas1CN3 + + + + IgG1(K) Pas1CN4 + - + - IgG1( K) Pas1CN5 + - + - IgG1(K ) Pas1CN6 + - + - IgG1 ( K ) [0055] 2) Combination conditions in sandwich ELISA By using PaslCN1, Pas1CN2 and PaslCN3 selected by direct ELISA, sandwich ELISA was performed for all the. combinations of MAbs. Combinations of MAbs to detect aCN or CN were selected by sandwich ELISA by using PaslCN1, PaslCN2, PaslCN3 as a solid-phased or a biotinylated antibody, respectively. As a result, the combination of PaslCN1 (FERM ABP-10263) and PaslCN2 (FERM ABP-10264) was selected as a combination enabling detection of N-ctCN, D-ccCN, N-CN and D-CN. The results are shown in Fig. 1. 2. Epitopes recognized by PaslCN1 and PaslCN2 aXsl casein solution was degraded with lysyl endoprotease and the degradation products were separated by trycin SDS-PAGE (separation gel 16.5%, concentration gel 5%). By using the separated gel, the resultant was transcribed to a PVDF membrane by electroblotting. After allowing the culture supernatant of PaslCN1 and PaslCN2 (1/1000) to react to the transcribed PVDF membrane, the recognized epitopes were confirmed by coloring. The results are shown in Fig. 2. As a result, recognition sites of both PaslCNl and PasCN2 was the 132 - 193 position 40 of the amino acid sequence of asl casein shown by SEQ ID NO: 1, with a molecular weight of about 7000. [0056] 3. Detection of native and denatured casein in foods by ELISA It was investigated whether casein in actual foods could be detected by using the combination of PaslCN1 and PaslCN2 selected in the above 1. [0057] 3-1 Materials and methods 1) Preparation of meat product models Meat products were selected as food models for a quantitative test, and meat product models containing sodium casein at each concentration were prepared in a composition shown in Table 2. Fats and muscles were removed from pork loin meat, and minced to 5 mm, and the resultant was used as lean hog. [0058] [Table 2] Composition list of meat product models Raw material TEST1 TEST2 TEST3 Control Lean hog ( % ) 83.0 83.0 83.0 83.0 NaCl (%) 2.0 2.0 2.0 2.0 Sodium polyphosphate (%) 0.2 0.2 0.2 0.2 Sodium nitrite (ppm) 120 120 120 120 Sodium ascorbate (ppm) 300 300 300 300 water 14.5 14.5 14.5 14.5 Sodium casein(ppm) 200 20 2 0 41 Total (%) 99 .762 1 99 .74 4 199.2422 1 99.742 [0059] According to each composition, additives were measured, and mixed with a food processor, filled into a vinyl chloride tube, which was heated at 75*C for 30 min. 2) Quantitative analysis by sandwich ELISA Each meat product model was ground until being homogenized with a food processor, and used as a sample for analysis. 2 g of sample was measured and taken, 38 g of PBST containing 1 M of urea and 0.1% of 2-mercaptoethanol was added, and the resultant was heat treated at 100 0 C for 1 hour. After cooling, centrifugation was performed at 3,000 rpm for 20 min, and 9.5 ml of PBST was added to 0.5 ml of supernatant and the resultant was used as a sample for ELISA. Serial dilution of sodium casein treated similarly with urea and 2-mercaptoethanol was used for a standard curve. Further, comparison was carried out with the case where urea and 2-mercaptoethanol were not used and using sodium casein as a standard curve which was extracted from a sample for analysis by using PBST, and dissolved in PBST (PBS added with 0.5% polyoxyethylene sorbitan monolaurate). [0060] 3-2 Results The results of sandwich ELISA by using urea and 2-mercaptoethanol for analysis of sodium casein in food product models are shown in Table 3, and the results of extracting sodium casein with only PBST are shown in Table 42 4. [00611 [Table 3] TEST 1 TEST 2 TEST 3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 235.4 16.4 1.5 N.D. *2 Yield (%) *1 117.7 82.0 75.0 * 1: ( assay value / added amount ) x 100 *2 not detected [0062] [Table 4) TEST 1 TEST 2 TEST 3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 16.1 1.7 N.D.*2 N.D. Yield (%) *l 8.1 8.5 *1: ( assay value / added amount ) x 100 *1 not detected [0063] From the above results, when urea and 2-mercaptoethanol are added to the extraction solution, sodium casein in meat product models can be detected at a high yield, while it showed a significant low yield in PBST extraction. From these results, it was revealed that it is effective to use urea and 2-mercaptoethanol for extracting sodium casein from foods, and for the characteristics of MAbs used therein, it is necessary that the MAbs are bondable to urea-solubilized casein. 43 [0064] 4. Detection of denatured and native sodium casein by immunochromatography 4-1 Materials and methods 1) Preparation of gold colloid labels and conjugate pads MAb solution of PaslCN1 was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0). 500 ptl of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30 min, 625 tl of 10% BSA solution was added and was further allowed to react for 15 min. Centrifugation was performed and it was prepared to OD525=l.0 with 1% BSA solution. The resultant was applied to a glass wool conjugate pad to 68 41/cm 2 , and dried. [0065] 2) Preparation of antibody fixed membranes MAb solution of PaslCN2 was prepared to 4 mg/ml with PBS, applied linearly on a nitrocellulose membrane and dried. Then, the resultant was blocked for 2 hours, at 37'C, with PBS containing 1% BSA and 0.1% Tween 20. [0066] 3) Construction and estimation of immunochromato strips A sample pad, a conjugate pad, an antibody-fixed membrane and an absorption pad prepared in the above were applied respectively, to make an immunochromato strip. Meat product models prepared in the above were diluted appropriately and used as a test solution. [0067] 44 4-2 Results By using the combination of PaslCN2 and gold colloid labeled-PaslCN1, sodium casein could be detected heated or non-heated, up to 50 ppb (2 ppm in food). From this result, it was revealed that immunochromato stip that can respond to any case could be constructed, even when native sodium casein which had been mixed during the manufacture process was the target, or when a product after heating was the target. [0068] When PBS containing only 0.01 M of urea as a blank was dropped to a commercial immunochromato strip for detecting allergens, a non-specific band appeared, and it was determined as false positive. Thus, a protein denaturant to detect effectively allergens from food protein which was denatured by heating and the like, could not be used, and there was a possible risk that subjects detectable as allergens would be limited to a very narrow range. [0069] 5. Establishment of anti-p-lactoglobulin monoclonal antibodies 5-1 Materials and methods 1) Preparation of -lactoglobulin (hereinafter sometimes referred to as "jLG") Crude fractions of whey were obtained from fresh milk, according to Zittle (1959). The crude fraction was further purified by using TSK gel DEAE 650S (TOSOH) with a linear gradient (0 to 0. 4M) of NaCl, and 50 mM of tris-HCl 45 buffer solution (pH 6.5). The purified LG fraction was dialyzed with distilled water and then lyophilized, to make a native PLG (hereinafter sometimes referred to as "N-3LG") . 10 mg of the N-PLG was measured, 1 ml of 1.4 M tris-HCl buffer solution (pH8.6), 100 ptl of 5% of EDTA, 1.2 g of urea, 33 pl of 2-mercaptoethanol were added to the N-ILG to make a constant volume of 2.5 ml, and a nitrogen gas substitution was performed. Then, the resultant was substituted to reduction treatment at 37 0 C for 1 hour, and 89 mg of monoiodoacetic acid dissolved into 300 [pl of 1M NaOH was added to perform a nitrogen gas substitution. Subsequently, carboxymethylation was performed at room temperature for 1 hour, to make a reduced carboxymethylated PLG (hereinafter sometimes referred to as "R-3LG") . A 0.1% solution of the lyophilizates was prepared with saline which was aliquoted in 1 ml-volume Eppendorf tubes at 500 pl per tube, and stored by freezing at -20*C until immunization, and was used as an antigen solution. [0070] 2) Immunization As test animals, 5 BALB-c mice (CLEA Japan) of 5 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 pl of 0.1% N-fLG or R-PLG, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pl per mouse. Further, additional immunizations were performed 3 times at 2 weeks interval. For 46 immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to each Eppendorf tube filled with 500 il of 0.1% N-3LG or R-3LG at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pl per mouse. [00711 3) Measurement of antibody titer in blood One week after injecting N-3LG or R-3LG as a first or additional immunization, blood was collected from tail vein ofeach BALB/cmouse. The blood collected was allowed to stand for 2 hours at room temperature, centrifuged to obtain serum. 10-fold dilution of these sera was prepared,and the anti-N-3LG antibody titer and anti-R-PLG antibody titer in mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibody (Jackson ImmunoResearch Laboratories Inc.) was used. [0072] 4) Preparation of hybridomas Hybridomas were prepared according to the methods of Keller and Milstein (1975). In other words, 100 il of 0.1% N-PLG solution or R-PLG solution was injected into tail vein of a mouse whose antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nilon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. 47 Spleen cells were harvested by centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3,350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, and the mixture was diluted, centrifuged to obtain a pellet. A HAT selective medium consisting of a hybridoma medium (RPMIl640 medium containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) and 100 iM of hypoxanthine, 0. 4 piM of aminopterin and 16 ptM of thymidine was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 37*C, in the presence of 5% C02. [0073] 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies of ELISA and producing anti-N-PLG antibody or anti-R-3LG antibody was examined for the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against aCN by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 48 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 media containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 ptg/ml of streptomycin were used for culturing cloned hybridomas. (0074] 6) Screening of antibodies To screen monoclonal antibodies, clones of different specificities were obtained by examining the difference of reactivity against 3 types of protein, N-3LG, R-3LG and urea-treated OLG (hereinafter referred to as "D-$LG"). D- LG was denatured by the following steps: 1 mg of purified N-pLG was measured, 6.0 g of urea, 0.2 ml of 2-mercaptoethanol, 1 ml of 50 mM tris-hydrochloric buffer solution (pH 8.6), 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, and heated at 100*C for 1 hour in an oil bath. The reactivity against N-BLG, R-BLG, or D-BLG of the culture supernatant was examined by non-competitive ELISA. [0075] 7) Collecting ascitic fluid and purification of MAb According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/well of cloned hybridomas per mouse were inoculated. After accumulation of ascitic fluid, the fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). (0076] 8) Classes, subclasses and types of MAbs 49 Solid-phase method was used to determine the characteristics of anti-N-3LGMAb or anti-R-PLGMAb. As solid-phase method, a method comprising the steps of fixing previously N-3LG, R-ILG or D-PLG in wells of cell culture plate and allowing anti-N-PLGMAb or anti-R-PLGMAb react to these fixed antigens, was used. Classes and subclasses of MAbs were determined according to Monoclonal mouse immuno cxCNobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y). [0077] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 ptl of NHS-biotin solution dissolved at 3 mg/100 ptl in DMSO was added, and the mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS, to obtain 20 mg/ml. [0078] 5-2 Results 1) Characteristics, classes and subclasses of anti N-$LGMAb and anti-R-ILGMAb 13 types of MAbs having specificity against N-PLG were obtained. Specificity against each solid-phased antigen is shown in Table 5. [0079] [Table 5] MAbs N-pLG R-PLG D-pLG Classes, subclasses, and types 50 751(PpLG1) + + + IgG1( K) 752 + - - IgG ( K) 753 + - - IgG1 ( K) 756 + - - IgG ( K) 758 + - - IgG1 ( K ) 759 + - - IgG1( K) 761 + + - IgG2a ( K) 763 (PpLG2) + + + IgG1( K) 773 + + + IgG1(K) 778 + - - IgG1( K) 781 + - + IgG1( K) 788 + + - IgG1 ( K ) 790 - + - IgG1( K ) 796 (PpLG3) - + + IgG1( K) [0080] 2) Combination conditions in sandwich ELISA Each MAb having shown positive reaction to solid-phased antigen was used as solid-phased or biotinylated antibody to select combination of MAbs to detect N-jLG and D-OLG, from the point of view of high sensitivity in sandwich ELISA. As a result, as combinations that can detect N-PLG and D-PLG, plate fixed antibody PLG2 (FERM ABP-10282) and biotinylated antibody PLG1 (FERM ABP-10281) or PLG3 (FERM ABP-1028) were selected. Results of reactivity against N-PLG and D-ILG of PLG2 and PLG 1 by sandwich ELISA are shown in Fig. 3. Further, reactivity against N-3LG and D-3LG of PLG 2 and 51 PLG 3 by sandwich ELISA is shown in Fig. 4. [0081] 3) Detection of N-3LG, D-PLG in a MAb mixed system Combinations selected by sandwich ELISA (PLG2 for solid-phased, PLG1 and PLG 3 for biotinylated) were used to confirm detection sensitivity of N-PLG and D-$LG. As it is shown in Figs. 5 and 6, the optical density was higher in a MAb mixed system, for both N-PLG and D-3LG in a MAb mixed system, and it was revealed that it was possible to increase the detection sensitivity. [0082] 6. Detection of whey protein in foods by sandwich ELISA With the combinations of PLG2 and PLG1, and PLG2 and PLG3 selected in the above 1, it was investigated whether whey protein in actual foods could be detected. [0083] 6-1 Materials and methods 1) Preparation of meat product models Meat products were selected as food models for quantitative tests, meat product models containing whey protein at each concentration were prepared with a composition shown in Table 6. Fats and muscles were removed from pork loin meat, and minced to 5 mm, and the resultant was used as lean hog. According to each composition, additives were measured, mixed with a food processor, and filled into a vinyl chloride tube, which was heated at 75 0 C for 30 min. [0084] [Table 6] 52 Raw material TEST 1 TEST 2 TEST 3 Control Lean hog ( % ) 83.0 83.0 83.0 83.0 N a C I ( % ) 2.0 2.0 2.0 2.0 Sodium polyphosphate (%) 0.2 0.2 0.2 0.2 Sodium nitrite (ppm) 120 120 120 120 Sodium ascorbate(ppm) 300 300 300 300 water 14.5 14.5 14.5 14.5 Sodium casein (ppm) 200 20 2 0 Total ( % ) 99.762 99.744 99.7422 99.742 [0085] 2) Qualitative analysis by sandwich ELISA Each meat product model was ground until being homogenized with a food processor, and used as a sample for analysis. 1 g of sample was measured and taken, 19 g of PBST (PBS added with 0.5% polyoxyethylene sorbitan monolaurate) containing 10 M of urea, 0.1% of 2-mercaptoethanol was added, and the resultant was stirred for 30 sec with a homogenizer. Then, heat treatment at 1000C was performed for 1 hour. After cooling, centrifugation was performed at 3,000 rpm for 20 min, and 9.5 ml of PBST was added to 0.5 ml of supernatant and the resultant was used as a sample for ELISA. Serial dilution of whey protein treated with 10 M urea and 0.1% 2-mercaptoethanol was used for standard curve, similarly. Further, comparison was carried out with the case where urea and 2-mercaptoethanol were not used and using sodium casein as a standard curve which was extracted from a sample for analysis by using PBST, and dissolved in PBST. 53 [0086] 6-2 Results The results of using urea and 2-mercaptoethanol for analysis of whey protein in food product model by sandwich ELISA are shown in Table 7, and the results of extracting with only PBST are shown in Table 8. [0087] [Table 7] TEST 1 TEST 2 TEST 3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 170.5 18.7 2.3 N.D.*2 Yield ( % ) 1 85.3 93.5 115.0 *1 :( assay value / added amount) x1OO *2 not detected [0088] [Table 8] TEST 1 TEST 2 TEST 3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 0.1 N.D.*2 N.D. N.D. Yield ( %)*1 0.05 - *1 ( assay value / added amount ) x1OO *2 not detected [0089] From the above results, when urea and 2-mercaptoethanol are added to the extraction solution, whey protein in meat product models can be detected at a high yield, while in PBST extraction, detection was not 54 possible. From these results, it was revealed that it is effective to use urea and 2-mercaptoethanol for extracting whey protein from foods, and as for the characteristics of MAbs used in that case, it is necessary that the MAb are bondable to urea-denatured LG. [0090] 7. Detection of denatured and native sodium casein by immunochromatography 7-1 Materials and methods 1) Preparation of gold colloid labeled and conjugate pad MAb solution of PLG1 and PLG3 was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0). 500 1 of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30 min, 625 pl of 10% BSA solution was added and was further allowed to react for 15 min. It was prepared to OD525=2.0 with 1 % BSA solution, and mixed at a ratio of 1 : 1. The resultant was applied to a glass wool conjugate pad to 68 ptl/cm 2 , and dried. [0091] 2) Preparation of antibody fixed membranes MAb solution of PLG2 was prepared to 4 mg/ml in PBS, and dried by applying linearly on a nitrocellulose membrane. Then, the resultant was blocked for 1 hour, at 37*C, in 10 mM of phosphate buffer (pH 7.5) containing 1% BSA, washed with 10 mM acetate buffer (pH7.5) , then dried. [0092] 3) Construction and estimation of immunochromato strips 55 A sample pad, a conjugate pad, an antibody-fixed membrane and an absorption pad prepared in the above were applied respectively, to make an immunochromato strip. Meat product models prepared in the above 2. were diluted appropriately and used as a test solution. [0093] 7-2 Results With the combination of PLG2 which is a membrane-applied MAb, and PLGl+PLG3 which are gold colloid-labeled MAbs, whey protein could be detected heated as well as non-heated, up to 50 ppb (2 ppm in foods) . From this result, it was revealed that immunochromato stip that can respond to any case can be constructed, even when whey protein which has been contaminated during the manufacture process is the target, or when products after heating are the target. [0094] When PBS containing 0. 1 M of urea was dropped as a blank in a commercial immunochromato strip to detect allergens, a non-specific band appeared, and it was tested as false positive. Thus, a protein denaturant to detect effectively allergens from food proteins denatured by heating and the like could not be used, and there was a possible risk that subjects detectable as allergens would be limited to a very narrow range e. Example 2 [0095] 1. Establishment of MAbs bondable to denatured/native ovalbumin 56 1-1 Materials and methods 1) Preparation of chicken ovalbumin (hereinafter sometimes referred to as "OA") Only albumen was collected from fresh chicken eggs, homogenized without beating, saturated sulfate ammonium of an equal amount was added. The resultant was filtrated with a filter paper No. 1 (Advantec Toyo). 0.5 Mof sulfate was added to the obtained filtrate, adjusted to pH 4. 6 and allow to rest overnight. The precipitates obtained by centrifugation at 8000 rpm x 20 min were dissolved in distilled water, and were recristallized similarly, to obtain crude OA fractions. Crude OAs were further purified by ion exchange chromatography by using TSK gel DEAD 650S (Tosoh). For transfer phase, 50 mM of imidazol-chloride buffer solution (pH 6.4) was used, and OA was fractionated with 0 to 0.3 M linear gradient of NaCl. The resultant was desalted by dialysis, and lyophilized. The lyophilized OAs were used to prepare 0.1% OA solution with saline solution, and aliquoted at 500 ptL in lml-volume Eppendorf tubes to make an antigen solution which was stored by freezing at -20*C until immunization. [0096] 2) Immunization As test animals, 4 BALB/c mice (CLEA Japan) of 6 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 tl of 0.1% OA at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an 57 amount of 150 tl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to each Eppendorf tube filled with 500 pl of 0.1% OA at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pilper mouse. Meanwhile, when obtaining anti-denatured OAMAb, a reduced carboxymethylated OA, described in the following, was used only for the last immunization. [0097] 3) Measurement of antibody titer in blood One week after injecting OA as the primary or additional immunization, blood was collected from tail vein ofeach BALB/cmouse. The blood collected was allowed to stand for 2 hours at room temperature, centrifuged to obtain serum. 10-fold serial dilution of these sera was prepared, and the anti-OA antibody titer in mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0098] 4) Preparation of hybridomas Hybridomas were prepared according to the methods of Keller and Milstein (1975) . In other words, 100 [tl of 0.1% OA solution was injected to tail-vein of a mouse whose antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after 58 intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3, 350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective consisting of a hybridoma medium (RPMIl640 medium containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) and 100 tM of hypoxanthine, 0.4 piM of aminopterin and 16 ptM of thymidine was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 370C, in the presence of 5% C0 2 . [0099) 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies for ELISA and producing anti-OA antibodies was examined in the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against cxCN by ELISA were transferred to a 96-well cell culture 59 plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 media containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 g/ml of streptomycin were used for culturing cloned hybridomas. (0100] 6) Screening of antibodies To screen monoclonal antibodies, clones of different specificities were obtained by examining the difference of reactivity of native OA (hereinafter sometimes referred to as "NOA"), or reduced carboxymethylatedOA (hereinafter sometimes referred to as "RCMOA") . For RCMOA, 10 mg of purified OA (the above lyophilizates) was measured, 1 ml of 1.4M tris-chloride buffer solution (pH 8.6), 100 pl of 5% EDTA, 1.2 g of urea, 33 tl of 2-mercaptoethanol were added to make a constant volume of 2.5 ml, and a nitrogen gas substitution was performed. Then, the resultant was subjected to a reduction treatment at 37 0 C for 1 hour. Further, 89 mg of monoiodoacetic acid dissolved into 300 ptl of 1 M NaOH was added to perform a nitrogen gas substitution, and the resultant was carboxymethylated at room temperature for 1 hour, to make a RCMOA. The reactivity against NOA or RCMOA of the culture supernatant was examined by non-competitive ELISA. [0101] 7) Collecting ascitic fluid and purification of MAbs According to Jones et al. (1990), 0.2 ml of 60 incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/well of cloned hybridomas per mouse were inoculated. After accumulation of ascitic fluid, the fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [01011 8) Characteristics of MAbs, classes and subclasses of MAbs Solid-phase method and liquid-phase method were used to determine the characteristics of anti-OAMAbs. As a solid-phase method, a method comprising the steps of fixing NOA or RCMOA previously in wells of cell culture plate and to allowing anti-native/denatured OAMAbs to these fixed antigens (NOA or RCMOA), was used. As liquid-phase method, a method comprising the steps of fixing rabbit anti-OA polyclonal antibodies in wells of cell culture plate, and allowing anti-native/denatured OAMAbs to these polyclonal antibodies while NOA or RCMOA are bound. Classes and subclasses of MAbs were determined according to Monoclonal mouse immunoglobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y) [0103] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 tl of NHS-biotin solution dissolved at 3 mg/100 ml in DMSO was added, and the mixture was stirred and then allowed to 61 stand for 2 hours by icing. Subsequently, it was replaced with PBS, to obtain 20 mg/ml. [0104] 1-2 Results 1) Characteristics, classes and subclasses of anti-OAMAbs 9 types of MAbs having specificity against NOA and 10 types of MAbs having specificity against RCMOA were obtained. Specificity against each of solid-phased and liquid-phased antigens is shown in Table 9, respectively. [0105] [Table 9] MAbs Solid Liquid Solid Liquid Classes, phased phased phased phased subclasses, and NOA NOA RCMOA RCMOA types 301B5 + + - - IgG1( K) 304E4 (PNOA1) + + - - IgG1 ( K ) 305G5 + + - - IgG1(K) 306B2(PNOA2) + + - - IgGI ( K) 307G4 + - - - IgG1( K ) 310G7 + + - - IgG1( K) [010 6] 311E1i + - - - IgG1 ( K ) 314E12 + + - IgG ( K ) 316G1 + + - - I( ) 63E5 + - + + IgG1( K) 65F2 + - + + IgG1( K) 68G4 + - + + IgG1( K ) 69H6 + - + + IgG1 () 74G2 + - + + IgG1( K) 62 115F8 + - + + IgGI (K) 117F9 + - + + IgGI (x) 119D11 + - + + IgGI (K) 948G11(PDOA1) + - + + IgG1 (K) 962B8(PDOA2) + - + + IgGi (K) [0107] 2) Combination conditions Combinations of MAbs for detecting NOA or MAbs for detecting RCMOA were selected from the point of view of detection sensitivity by sandwich ELISA. As a result, 301B5 and 316G1, or 304E4(PNOA1; FERMABP-10265) and 306B2 (PNOA2, FERM ABP-10266) were selected for NOA, and 117F9 and 119D11, or 948G11 (PDOAl; FERM ABP-10275) and 962B8 (PDOA2; FERM ABP-10276) were selected for RCMOA as combinations with high detection sensitivity. Should the following examples be rewritten from 301B5 and 316G1/117F9 and 119D11 to 304E4 and 306B2/948G11 and 962B8. [0108] 2. Detection of denatured and native antigens by sandwich ELISA 2-1 Materials and methods NOA solution was prepared so that purified OA becomes 100 ppb solution with PBS, and 3-fold serial dilution was prepared (serial dilution A). On the other hand, 1 mg of purified OA was measured in a glass tube, 6 g of urea, 0.2 ml of 2-mercaptoethanol, 1 ml of 50 mM tris-hydrochloric 63 buffer solution (pH 8.6) and 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, and heated at 100'C for 1 hour in an oil bath, to perform a denaturation treatment. After cooling, the resultant was transferred to 100 ml volume female flask, and messed up to 100 ml with PBS. The resultant was further diluted to 100-fold with PBS and used as urea-denatured OA (hereinafter referred to as "UDOA") 100 ppb solution. Subsequently, 3-fold serial solution was prepared by maintaining the urea concentration to 0.01M (serial dilution B). Further, equivalent amounts of 100 ppb solution of NOA and 100 ppb solution of UODA were mixed (NOA and UDOA become 50 ppb solution, respectively) , and 3-fold serial dilution was prepared by maintaining the urea concentration to 0.005 M (serial dilution C). Conditions of sandwich ELISA are shown in Table 10. Concentration of coating MAb was set to 25 pg/ml when used alone, and 12.5 ptg/ml each when mixed, so that the total is 25 ptg/mg. [0109] [Table 10] Test Coating MAbs Antigens Secondary No. antibodies Test 1 301B5 Serial Mixture of 316G1 119D11 dilution A and 117F9 Mixture of 301B5 and (native) 119Dll Test 2 301BS Serial 119D11 dilution B Mixture of 301B5 and (denature 119Dl1 d) Test 3 301B5 Serial 119D11 dilution C 64 Mixture of 301B5 and 119D11 [0110] 2-2 Results As it is shown in Fig. 7, in Test 1 targeting native OA, curves for 301B5 alone and for a mixture of 301B5 and 119D11, almost lapped over. However, in a thinner condition such as less than 10 ppb, the absorbance level was slightly higher for the curve for 301B5 and 119Dll mixed, compared to the curve for 301B5 alone. Thus, it was considered that the detection sensitivity could be increased. Further, for UDOA in Test 2 targeting denatured OA, no absorbance level was observed for 301B5 alone, and it was thought that 301B5 and 316G1 were not related to UDOA. However, the absorbance level was clearly higher for the curve of a mixture of 301B5 and 119Dll compared to the curve for 119D11 alone. Thus, it was thought that the detection sensitivity could be increased by mixing MAbs (Fig. 8). This result was also observed in Test 3 targeting native/denatured OA, and the absorbance level was clearly higher for a mixture of 301B5 and 119D11, compared to 301B5 alone (Fig. 9). For any of Tests 1 to 3, the concentration of antibody when coated alone was 25 g/ml, and when coated as a mixture of antibodies, the concentration was half, that is 12.5 mg/ml. Therefore, it was revealed that by using a mixed system which increases the types of MAbs, the detection sensitivity of antigen could be enhancedmore, even though the antibody concentration is the same or less. 65 [0111] 3. Detection of denatured and native OA by immunochromatography 3-1 Materials and methods 1) Preparation of gold colloid labeled and conjugate pad MAb solution of 119D11 and 316G1, alone or mixed, was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0). 500 [l of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30min, 625 pl of 10% BSA solution was added and was further allowed to react for 15 min. It was prepared to OD525 = 1.0 with 1 % BSA solution. The resultant was applied to a glass wool conjugate pad (Nihon Millepore) to 68 [pl/cm 2 , and dried. [0112] 2) Preparation of antibody fixed membranes MAb solution of 117F9 and 301B5, alone or mixed, was prepared to 4 mg/ml in PBS, and dried by applying linearly on a nitrocellulose membrane. Then, the resultant was blocked for 2 hours at 37"C, in PBS containing 1% BSA and 0.1% Tween 20, washed with PBS and dried. [0113] 3) Construction and estimation of immunochromato strips Beside a conjugate pad and an antibody-fixed membrane prepared in the above, a sample pad made by glass wool for test solution spot, an absorption pad made by glass wool for absorption of test solution were prepared. 66 The sample pad, conjugate pad, antibody-fixedmembrane and absorption pad were applied subsequently to make an immunochromato strip. NOA and UDOA prepared in the above 2 were diluted appropriately and used as a test solution. (0114] 3-2 Results With the combination of 301B5 and gold colloid labeled 316G1, NOA could be detected up to 10 ppb. However, UDOA was not detected, even in an amount of 1 ppm. On the other hand, with the combination of 117F9 and gold colloid labeled 119D11, UDOA could be detected up to 10 ppb, while NOA was not detected even in an amount of 1 ppm. On the contrary, when an immunochromato strip was prepared by using a fixed antibody mixture of 301B5 and 117F9, and a gold colloid antibody mixture of 316G1 and 119D11, denatured OA or native OA could be detected up to 10 ppb. By combining MAbs bondable to denatured OA with MAbs bondable to native OA, it is possible to construct an immunochromato strip that can respond to any case, even if a denatured albumen mixed during manufacture is the target, or if a product after heating is the target. [0115] When PBS containing only 0.01 M of urea as a blank was dropped to a commercial immunochromato strip for detecting allergens, a non-specific band appeared, and it was tested as false positive. Thus, urea which is a protein denaturant to extract albumen allergens which has been insolubilized by heat, etc. could not be used, and there was a possible risk that subjects detectable as 67 allergens would be limited to a very narrow range. [0116] 4. Establishment of MAb bondable to denatured/native ovomucoid 4-1 Materials and methods 1) Preparation of chicken ovomucoid (hereinafter referred to as "OM") Only albumen was collected from fresh chicken egg, homogenized without beating, and the resultant was mixed with an equivalent amount of 0.1 M acetate buffer solution (pH 3.8). Subsequently, dialysis was performed to 0.1 M acetate buffer, and the resultant was centrifuged at 8,000 rpm x 20 min to collect the supernatant. Further, the resultant was purified by ion exchange chromatography by using TSK gel DEAE 650S (Tosoh) . For transfer phase, 50 mM of imidazol-chloride buffer solution (pH 6.4) was used, and OM was fractionated with 0 to 0.3 linear gradient of NaCl. The resultant was desalted by dialysis and lyophilized, which were used as native OM (hereinafter sometimes referred to as "NOM") . 1 mg of the purified OM was measured, to which 6 g of urea, 0.2 ml of mercapto-ethanol, 1 ml of 50 mM tris-chloride buffer and 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, heated in an oil bath at 100*C for 1 hour to perform a denaturation treatment, to make a urea-denatured OM (hereinafter sometimes referred to as "DOM") . 0.1% solution of these lyophilizates was prepared with a saline solution, aliquoted at 500 ptl in lml-volume Eppendorf tubes to make an antigen solution which was 68 stored by freezing at -20*C until immunization. [0117] 2) Immunization As test animals, 4 BALB/c mice (CLEA Japan) of 6 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 tl .of 0.1% NOM or DOM, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pLl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to each Eppendorf tube filled with 500 [il of 0.1% NOM or DOM at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 41 per mouse. [0118] 3) Measurement of antibody titer in blood One week after injecting NOM or DOM as the primary or additional immunization, blood was collected from tail vein ofeach BALB/cmouse. The blood collected was allowed to stand for 2 hours at room temperature, centrifuged to obtain serum. 10-fold serial dilution of these sera was prepared, and the anti-OM antibody titer in mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0119] 69 4) Preparation of hybridomas Hybridomas were prepared according to the methods of Keller and Milstein (1975) . In other words, 100 ml of 0.1% NOM solution or DOM solution was injected to tail-vein to a mouse which antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cellsuspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3,350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective medium consisting of a hybridoma medium (RPMI1640 medium containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) and 100 ptM of hypoxanthine, 0.4 tM of aminopterin and 16 FM of thymidine was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 370C, in the presence of 5% C0 2 . [0120] 70 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies of ELISA and producing anti-NOM antibodies or anti-DOM antibodies was examined in the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against NOM or DOM by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 media containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100U/ml of penicillin, 100 g/ml of streptomycin were used for culturing the cloned hybridomas. [0121] 6) Collecting ascitic fluid and purification of MAb According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/well of cloned hybridomas were inoculated per mouse. After accumulation of ascitic fluid, the fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [0122] 8) Characteristics of MAbs, classes and subclasses of MAbs Solid-phase method and liquid-phase method were used to determine the characteristics of anti-NOMMAbs and anti-DOMMAbs. As solid-phase method, a method comprising 71 the steps of fixing NOM or DOM previously in wells of cell culture plate and allowing MAbs to react to these fixed NOM or DOM, was used. As liquid-phase method, a method comprising the steps of fixing rabbit anti-ovomucoid polyclonal antibodies in wells of cell culture plate, and allowing MAbs react to these polyclonal antibodies while NOM or DOM are bound. Classes and subclasses of MAbs were determined according to Monoclonal mouse immunoglobulin isotyping kit (Pharmingen) as IgGl, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y) [0123] 8) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 ml of NHS-biotin solution dissolved at 3 mg/100 ptl in DMSO was added, and the mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS, to obtain 20 mg/ml. [0124] 4-2 Results 1) Characteristics, classes and subclasses of anti-NOMMAbs and anti-DOMabs 7 types of MAbs having specificity against NOM and 10 types of MAbs having specificity against DOM were obtained. Specificity against each of solid-phased and liquid-phased antigens is shown in Table 11, respectively. [0125] [Table 11] 72 MAbs Native Native Denatured Denatured Classes, solid liquid solid phased liquid subclasses, and phased phased OM phased OM types OM OM 47E5 (PNOM1) + + - - IgG2a ( K) 50A12 (PNOM2) + + - - IgG1 ( K) 52C6 + + - - IgG1 ( i-) 53E11 + - - - IgG1( K) 56E4 + + - - IgM( K) 57G12 + - - - IgM ( ) 60C11 + - - - IgG1 ( ) 628E1 (PDOM1) - - + + IgG1 ( K ) 640G11 - - + + IgG1( K) 645B5 - - + + IgG1( K ) 648A9 (PDOM2) - - + + IgG1 ( K ) 658B6 - - + + IgG1( K ) 663A9 - - + + IgG1( K) 668D6 - - + + IgG1( K) 670E1 - - + + IgG1( ,) 671H8 - - + + IgG1( K) 674A4 - - + + IgG1( K) [0126) 2) Combination conditions Combinations of MAbs for detecting NOM were selected from the point of view of detection sensitivity by sandwich ELISA. As a result, the combination of 47E5 (PNOMl; FERM ABP-10279) and 50A12 (PNOM2; FERM ABP-10280) was selected as a combination with high detection sensitivity. Further, sandwich ELISA was performed by using the above 73 10 monoclonal antibodies, and those having the highest sensitivity, 628E1 (PDOMl; FERM ABP-10277) and 648A9(PDOM2; FERM ABP-10278) were selected as a combination having high detection sensitivity. [0127] 3) Reactivity of each monoclonal antibody and OM by sandwich ELISA By sandwich ELISA of PNOM1 and PNOM2, native ovomucoid was detected, while denatured ovomucoid was not detected at all (Fig. 10) . Further, by sandwich ELISA of PDOM1 and PNOM2, denatured OM was detected, but for native OM, sensitivity was low, in an amount between 10 to 100 ppb (Fig. 11). However, by sandwich ELISA wherein each monoclonal antibody is combined, by using PNOM2 and PDOM2 as plate antibodies, and PNOM1 and PDOM1 as biotin antibodies, detection sensitivity for native OM at 10 to 100 ppb was especially enhanced (Fig. 12). 5. Detection of albumen using OM as index by immunochromatography [0128] 5-1 Materials and methods 1) Preparation of gold colloid labels and conjugate packs MAb solution of PNOM1 was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0). 500 ptl of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30 min, 625 pLl of 10% BSA solution was added and was further allowed to react for 15 min. 74 Centrifugation was performed to OD525=1.0 with 1 % BSA solution. The resultant was applied to a glass wool conjugate pad to 68 1tl/cm 2 , and dried. [0129] 2) Preparation of antibody fixed membranes MAb solution of PNOM2 was prepared to 4 mg/ml in PBS, and dried by applying linearly on a nitrocellulose membrane. Then, the resultant was blocked for 2 hours, at 37'C, in PBS containing 1% BSA and 0.1% Tween 20. 3) Construction and estimation of immunochromato strips Besides a conjugate pad and an antibody-fixed membrane prepared in the above, a sample pad made by glass wool for test solution spot, an absorption pad made by glass wool for absorption of test solution were prepared. The sample pad, conjugate pad, antibody-fixedmembrane and absorption pad were applied subsequently to make an immunochromato strip. 0.1% solution of lyophilized albumen powder, treated for 1 hour at room temperature, 500C, 750C and 1000C, respectively, was diluted appropriately and used as a test solution. [0131] 5-2 Results With the combination of PNOM1 and gold colloid labeled PNOM2, albumen solution which has been treated for 1 hour at room temperature and 50*C could be detected up to 10 ppb. Further, albumen which has been treated for 1 hour at 75*C and 100'C, could be detected up to 100ppb. From this result, for foods which have been subjected to heat-treatment corresponding to a treatment for 1 hour at 75 1000C, even by not using a denaturant such as urea, albumen could be detected up to 100ppb by a simple extraction by using an immunochromato strip of this anti-OMMab. However, as detection was not possible with a heat treatment exceeding 1000C by an immunochromatography of OM, a solubilized treatment by urea, such as in the above, was necessary. [0132] 6. Effect of using in combination anti-OA MAbs and anti-OM Mabs 6-1 Methods From the above result, an immunochromato strip using PNOA1, and a fixed antibody mixture of PDOAl and PNOM1, as well as PNOA2 and a gold colloid antibody mixture of PDOA2 and PNOM2 were prepared as mentioned in the above, and detection of albumen was tried. [0133] 6-2 Results As it is shown in the above, with the combinations PNOAl and PNOA2, PDOAl and PDOA2, and PNOM1 and PNOM2, the desired denatured/native OA or OM could be detected with respective sensitivity. From this result, a method for detecting albumen was developped, wherein MAbs against native OA and OM react when it is non-heated, and MAbs against native/denatured OA and OM reacts when it is 50'C to 1000C, and denatured OA reacts by a solubilization treatment by urea when the temperature is higher than that, during the manufacturing process of processed foods. Example 3 76 [0134] 1. Establishment of MAbs bondable to denatured/native flour gliadin 1-1 Materials and methods 1) Preparation of flour gliadin (hereinafter referred to as "GL") 2-fold amount of n-butanol was added to flour for defatting, and the resultant was allowed to air dry for overnight. 2-fold amount of 0.1% sodium chloride solution was added to the obtained defatted flour and the resultant was centrifuged at 10,000 rpm x 15 min. 20-fold amount of 0.01 N acetate was added to the obtained precipitates, and the mixture was stirred and centrifuged at 10,000 rpm for 15 min. The obtained supernatant was dialyzed with distilled water and lyophilized. Ethanol was added to the obtained lyophilizates to 70%, and the resultant was centrifuged at 10,000 rpm x 15 min. The obtained supernatant was dialyzed with distilled water to obtain crude GL fractions. The GL fractions were further purified by gel filtration using Sephacryl S-200HR (Amersham Biosciences). For transfer phase, Gls were fractionated with 0.1 N acetate, dialyzed with distilled water and lyophilized. 0.1% solution of the lyophilizates was prepared with saline, and aliquoted at 500 ptl to 1 ml-volume Eppendorf tubes. The resultant was stored by freezing at -20*C until immunization and was used as antigen solution. [0135] 2) Immunization 77 As test animals, 5 BALB/c mice (CLEA Japan) of 5 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 pl of 0.1% GL at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to an Eppendorf tube filled with 500 pl of 0.1% GL at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 pl per mouse. [0136] 3) Measurement of antibody titer in blood One week after injecting GL as the primary or additional immunization, blood was collected from tail vein ofeach BALB/cmouse. The blood collected was allowed to stand for 2 hours at room temperature, centrifuged to obtain serum. 10-fold serial dilution of these sera was prepared, and the anti-GL antibody titer in mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0137] 4) Preparation of hybridomas Hybridomas were prepared according to the method of 78 Keller and Milstein (1975). In other words, 100 ptl of 0.1% GL solution was injected to tail-vein to a mouse whose antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after intravenous injection. The spleen was chopped, subsequently washed with RPMT 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3, 350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective medium consisting of a hybridoma medium (RPMI1640 medium containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) and 100 ptM of hypoxanthine, 0 .4 tM of aminopterin and 16 piM of thymidine was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 37*C, in the presence of 5% C02. [01381 5) Cloning by limiting dilution Presence of hybridomas provided as primary 79 antibodies of ELISA and producing anti-GL antibodies was examined in the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against GL by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 medium containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100U/ml of penicillin and 100 pg/ml of streptomycin was used for culturing the cloned hybridomas. [0139] 6) Screening of antibodies To screen monoclonal antibodies, clones of different specificities were obtained by examining the difference of reactivity against native GL (hereinafter referred to as "NGL"), reduced carboxymethylated GL (hereinafter referred to as "RCMGL"), GL solubilized with 0.1 M acetate (hereinafter referred to as "AGL"), GL solubilized with 70% ethanol (hereinafter referred to as "EGL"), and GL solubilized with a denaturant (hereinafter referred to as "DGL") . For RCMGL, 10 mg of purified GL was measured, 1 ml of 1.4 M tris-hydrochloric acid (pH8.6), 100 p.l of 5 % EDTA, 1.2 f of urea and 33 p.l of 2-mercaptoethanol were added to make a constant volume of 2.5 ml, and nitrogen gas substitution was performed. The resultant was subjected to a reduction treatment at 37*C for 1 hour. Further, 89 mg of monoiodoacetic acid dissolved into 300 80 pil of 1M NaOH was added to perfume a nitrogen gas substitution and the resultant was carboxymethylated at room temperature for 1 hour, to obtain RCMGL. Reactivity against NGL, RCMGL, AGL, EGL and DGL of the culture supernatant was examined by non-competitive ELISA. [0140] 7) Collecting ascitic fluid and purification of MAbs According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/well of cloned hybridomas per mouse were inoculated. After accumulation of ascitic fluid, fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [0141] 8) Classes, subclasses and types of MAbs Classes and subclasses of MAbs were determined according to Monoclonal mouse immunoglobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y). [0142] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 tl of NHS-biotin solution dissolved at 3 mg/100 ml in DMSO was added, and the mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS, to 20 mg/ml. 81 (0143) 2-2 Results 1) Selection of MAbs Gliadin (GL) which is a main allergen of flour is a protein insoluble to water, and soluble to acetate or ethanol. Therefore, GL solubilized in PBS (NGL) , reduced carboxymethylated GL (RCMGL), GL solubilized with 0.1M acetate (AGL), GL solubilized with 70% ethanol (EGL), GL solubilized with a denaturant (DGL) were prepared and it was investigated to which state of GL the antibody binds specifically. The results of direct ELISA for anti-GLMAbs against GL in each of the above states are shown in Table 12. As it is shown in Table 1, PGL1 (FERM BP-10267), PGL2 (FERM BP-10268), PGL4 and PGL7 which are MAbs that bind to GL in any of the states, were selected. [0144] [Table 121 NGL RGL AGL EGL DGL Classes, I subclasses and types PGL1 0 0 0 0 0 IgGl(K) PGL2 0 0 0 0 0 IgGl(K) PGL3 o o x o IgGl(K) PGL4 0 0 0 o o IgGl(K) PCL5 0 0 IgG1(K) PGL6 0 x 0 0 0 IgGl(K) PGL7 0 0 0 0 0 IgGI(K) PGL8 0 L 0 x 0 IgGl(IK) 82 [0145] 2) Combination conditions in sandwich ELISA By using PGL1, PGL2, PGL4 and PGL7 selected by direct ELISA, sandwich ELISA was performed to all of the MAb combinations. NGL, RCMGL, AGL, EGL and DGL were used for gliadin. As a result, the combination with which GL could be detected highly in any state was the combination of PGL1 and PGL2. The results of sandwich ELISA using PGL1 and PGL2 are shown in Table 13. For other combinations, all of GLs could not be detected or the detection sensitivity was very low by sandwich ELISA. From the above result, PGL1 and PGL2 were selected as MAbs detecting GL contained in various states in foods. [0146] 2. Difference of epitopes recognized by PGL1 and PGL2 In order to determine epitopes recognized by each antibody, by immunoblotting, immnoblotting was performed following A-PAGE and electroblotting. First, flour gliadin was separated by A-PAGE according to Lafiandra, D. & Kasarda, D. D. (Cereal Chemistry, 62, 314-319, 1985). By using the separated gel, it was transcribed on a PVDF membrane by electroblotting. AfLer allowing to react the culture supernatant of PGL1 and PGL2 to the transcribed PVDF membrane, the recognized epitopes were confirmed by coloring. As a result, as it is shown in Fig. 14, the protein degradation band recognized by PGL1 was not recognized by PGL2. From this result, it was revealed that PGL1 and PGL2 recognize different epitopes. [0147] 83 3. Detection of denatured and native GL by immunochromatography 3-1 Materials and methods 1) Preparation of gold colloid labels and conjugate pads PLG1 (or PLG2) solution was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0) . 500 jil of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30 min, 625 ptl of 10% BSA solution was added and was further allowed to react for 15 min. Centrifugation was performed and it was prepared to OD525=1 .0 with 1 % BSA solution. The resultant was applied to a glass wool conjugate pad (Japan Millipore) to 68 pl/cm 2 and dried. [0148) 2) Preparation of antibody fixed membranes PGL2 (or PGL1) solution was prepared to 4 mg/ml in PBS, applied linearly on a nitrocellulose membrane and dried. Then, the resultant was blocked for 2 hours, at 37'C, in PBS containing 1% BSA and 0.1% Tween 20, and washed with PBS and dried. [0149] 3) Construction and estimation of immunochromato strips Beside a conjugate pad and an antibody fixed membrane prepared in the above, a sample pad made by glass wool for test solution spot, an absorption pad made by glass wool for absorption of test solution were prepared. The sample pad, conjugate pad, antibody-fixed membrane and 84 absorption pad were applied in this order to make an immunochromato strip. [0150] The test solution was prepared as follows: 20-fold amount of PBST (0.5% polyoxyethylene sorbitan monolaurate added to PBS) was added to flour, the mixture was stirred at 4*C overnight, and the supernatant which had been defatted after centrifugation was collected. The resultant was dialyzed and the lyophilizates were prepared as a flour extract. By using the prepared flour extract, the solution which has been diluted with PBS was used as a native flour extract, and the solution which had been solubilized with a denaturant as denatured flour extract. [0151] 3-2 Results As GL of various states were detected by sandwich ELISA, a detection system by immunochromatography was established as an easier detection method, and estimated. For estimation, commercial A and B, which use the same antibodies as allergen detection kits currently on market were compared. The results are shown in Table 13. In Table 13, "non-specific reaction" is marked "present" when it was tested positive with only buffer solution. As a result, with commercial A, native flour extract was detected, while denatured flour extract could not be determined as no non-specific reaction was observed. Further, with commercial B, native flour extract was not detected even in an amount of 1 ppm, and a denatured flour extract could not determined as no non-specific reaction 85 was observed. With a method using a kit of the present invention, both native flour extract and denatured flour extract could be detected up to 50 bbp. Further, non-specific reaction was not observed for denatured flour extract. [0152] [Table 13] Flour extract (native) 1ppm 100pp 50ppb 10ppb Non-specific b reaction Method of the 0 0 0 X none present invention Commercial A 0 0 0 x none Commercial B x x x x none Flour extract (denatured) 1ppm 100pp 50ppb 1Oppb Non-specific b reaction Method of the 0 0 0 A none present invention CommercialA - - - - present Commercial B - - - - present [0153] Next, supposing to detect allergens from actual foods, estimation was performed by using commercially available bread. For estimation, commercial A and B, which use allergen detection kits currently on market were compared. The results are shown in Table 14. In Table 14, "non-specific reaction" is indicated "present" when it was tested positive with only a buffer solution. As the protein in bread is about 8%, the concentrations in the following are a number based on the estimation that 86 the content of 8% was fully extracted. As a result of estimation, with commercial A, native bread could not be detected at a concentration less than 4 ppm. For denatured bread, non-specific reaction was observed and determination was not possible. With commercial B, detection at about 4 ppm was possible while the detection was not possible at other concentrations. For denatured bread, non-specific reaction was observed and determination was not possible. With the method using a kit of the present invention, both native bread and denatured bread could be detected even at a concentration is as low as 40 ppb. Further, non-specific reaction was not observed for denatured bread, and detection was possible. [0154] [Table 14] Native bread (concentration is converted to protein concentration) 400pp 4ppm 400pp 40ppb Non-specific m b reaction Method of the 0 0 0 none present invention Commercial A x 0 X X none Commercial B 0 x x x none Denatured bread (concentration is converted to protein concentration) 400pp 4ppm 4 00pp 4 0ppb Non-specific m b reaction Method of the 0 0 0 A none present invention Commercial A - - - - present Commercial B - - - - present Example 4 87 [0155] 1. Establishment of anti-24kDa protein MAb and anti-76kDa protein MAb 1-1 Materials and methods 1) Preparation of buckwheat 24kDa protein MAbs and anti76kDa protein MAb 5-fold amount of purified water was added to commercially available buckwheat flour. The mixture was stirred and then centrifuged at 12000 rpm to obtain precipitates. 5-fold amount of 1M sodium chloride was added to the obtained precipitates. The mixture was stirred and then centrifuged at 12000 rpm to obtain supernatants. The supernatants were desalted by dialysis, lyophilized, and the obtained fractions were used as buckwheat crude protein fractions. The buckwheat crude protein fractions were further purified by using Prep Cell 960 (BioRad). Purification of 24kDa protein was performed as follows: buckwheat crude protein fractions were dissolved into a sample buffer containing 2.0% SDS and 5% 2-mercaptoethanol, and the resultant was heated at 95*C for 4 min, and used as a sample. The sample was fractionated with Prep Cell 960 by using acrylamide 12% separation gel, to obtain 24kDa protein. Purification of 76kDa Protein was performed as follows: buckwheat crude fractions were dissolved into a sample buffer containing 2.0% SDS and not containing 2-mercapto ethanol, and the resultant was used as a sample. The sample was fractionated with Prep Cell 960 using acrylamide 12% separation gel, to obtain 76kDa protein. Each of the 88 obtained fractions was lyophilized after dialysis. 0.1% 24kDa protein solution and 0.1% 76kDa protein solution were prepared by using these lyophilizates with saline, and were aliquoted at 500 [l into lml-volume Eppendorf tubes tomake an antigen solution. The solution was stored by freezing at -20'C until immunization. [0156] 2) Immunization As test animals, 5 BALB/c mice (CLEA Japan) of 5 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube each filled with 500 [1 of 0.1% 24kDa protein solution and 0.1% 76kDa protein solution at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 ptl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to each Eppendorf tube filled with 500 [l of 0.1% 24kDa protein solution and 0.1% 76kDa protein solution at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 [l per mouse. [0157] 3) Measurement of antibody titer in blood One week after injecting 24kDa protein solution or 76kDa protein solution as the primary or additional immunization, blood was collected from tail vein of each 89 BALB/c mouse. 10-fold serial dilution of these sera was prepared, and the anti-24kDa protein antibody titer and anti-76kDa protein antibody titer in mouse blood was examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0158] 4) Preparation of hybridomas Hybridomas were prepared according to the method of Keller and Milstein (1975) . In other words, 100 ptl of 0.1% 24kDa protein solution and 0.1% 76kDa protein solution were injected to tail-vein to a mouse which antibody titer has sufficiently increased. Spleen was extracted axenically from the mouse 4 days after intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson) , to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3,350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective medium consisting of a hybridoma medium (RPMIl640 medium 90 containing 10% bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin), 100 4M of hypoxanthine, 0.4 p.M of aminopterin and 16 p.M of thymidine was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 37*C, in the presence of 5% Co 2 . [0159] 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies of ELISA and producing anti-24kDa protein antibodies or anti-76kDa protein antibodies was examined in the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against 24kDa protein or 76kDa protein by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 medium containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 g/ml of streptomycin was used for culturing cloned hybridomas. [01601 6) Screening of antibodies To screen monoclonal antibodies, clones of different specificities were obtained by examining the difference of reactivity against 24kDa protein, 76kDa protein, buckwheat crude protein diluted in PBS (hereinafter 91 sometimes referred to as "NBW"), or buckwheat crude protein solubilized with a denaturant (hereinafter sometimes referred to as "DBW") . Buckwheat crude proteins were prepared by adding 20-fold amount of PBST to buckwheat flour, stirring the mixture overnight at 4 0 C, recovering the supernatant which has been defatted after centrifugation. The resultant was dialyzed and lyophilized, and was prepared as buckwheat flour extract. Solubilization with a denaturant was performed as follows: 10 mg of buckwheat crude protein was measured, 6 g of urea, 0.2 ml of 2-mercapto ethanol, 1 ml of 50 m Tris-HCl buffer solution (pH 8. 6) and 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, and heated at 100*C for 1 hour in an oil bath to perform a denaturation treatment. The resultant was used as DBW. Reactivity against 24kDa protein, 76kDa protein, NBW and DBW in the supernatant was investigated by non-competitive ELISA. [0161] 7) Collecting ascitic fluid and purification of MAb According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 106 cells/wellofcloned hybridomas per mouse were inoculated. After accumulation of ascitic fluid, fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [0162] 8) Characteristics of MAbs; Classes, subclasses and types of MAbs 92 Solid phase method was used to determine the characteristics of anti-24kDa protein MAb or anti-76kDa protein MAb. For solid phase method, 24kDa protein, 76kDa protein, NBW or DBW was previously fixed in a well of a cell culture plate. A method allowing anti-24kDa protein MAb or 76kDa protein MAb to the fixed antigens was used. Further, classes and subclasses of MAbs were determined according to Monoclonal mouse immunoglobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y). [0163] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 pl of NHS-biotin solution dissolved at 3 mg/100 pl in DMSO was added, and the mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS, to 20 mg/ml. [0164] 1-2 Results 1) Characteristics, classes and subclasses of anti-24kDa protein MAbs and 76kDa protein MAbs 5 types of MAbs having specificity against 24kDa protein, and 4 types of MAbs having specificity against 76kDa protein were obtained. Specificity against each solid phased antigens is shown in Tables 15 and 16. (0165] [Table 15) 93 MAbs 24kDa NBW DBW Classes, subclasses, and types 376 (PBW1) + - + IgG1(K) 384 + - + IgG1(K) 389 + - + IgG1(K) 398 + - + IgG1(K) 401 + - + IgG1(K) [0166] [Table 16] MAbs 76kDa NBW DBW Classes, subclasses, and types 505(PBW2) + + + IgGl( K ) 506(PBW3) + + + IgGl( K) 504 + + - IgGl ( K ) 512 + + - IgGl( K ) 501 + + - IgGl( K ) [0167] 2) Combination conditions Each MAb which showed a positive reaction against solid phased antigens was used as solid-phased or biotinylated antibodies, to select combinations of MAbs for detecting NBW and DBW from the view point of detection sensitivity in sandwich ELISA. As a result, as a combination for detecting NBW, a combination of plate fixed antibody PBW2 (FERM ABP-10273) with biotinylated antibody PBW3 (FERM ABP-10274) was selected. Further, as a combination for detecting DBW, a combination of plate fixed antibody PBWl (FERM ABP-10272) with biotinylated 94 antibody PBW2 was selected. The results of reactivity of PBW2 and PBW3 against various buckwheat crude proteins by sandwich ELISA are shown in Table 15. Further, the results of reactivity of PBW1 and PBW2 against various buckwheat crude proteins by sandwich ELISA are shown in Table 16. [0168] 3) Detection of NBW, DBW in a MAb mixed system Mabs selected by sandwich ELISA were mixed and the detection sensitivity of NBW and DBW was confirmed. In other words, for NBW, the case of using only PBW2 as plate fixed antibody was compared with the case of using a plate fixed antibody in which PBW1 and PBW2 are mixed, and a biotinylated PBW3 as secondary antibodies. Further, for DBW, the combination of a plate fixed antibody PBW1 with high detection sensitivity, with a biotinylated PBW2 was compared with the case of using a plate fixed antibody in which PBW1 and PBW2 are mixed, and a biotinylated PBW3 as secondary antibodies. As it is shown in Figs. 17 and 18, it was revealed that the absorbance was higher for both NBW and DBW when plate antibodies were mixed, and that detection sensitivity could be increased. [01691 Comparison of NBW detection 3.5 '3.
0 -0- plate antibody PBW2 2.5 biot inylated ant ibody BV V2.0 --- M-plate antibodies (PBW1+PBW2 ) 1.5 biotinylated antibody PBV\G 1.0 0.5 0.0 0.1 1 10 100 1000 antigen conce gations(ppb) [0170] 2. Detection of NBW, DBW in foods by sandwich ELISA With the combination of PBW1, PBW2 and PBW3 which was selected in the above 1. , it was investigated whether buckwheat crude proteins could be detected from actual foods. [0171] 2-1 Materials and methods 1) Preparation of meat product models Meat products were selected as food models for quantitative tests, and meat product models containing buckwheat crude proteins at each concentration were prepared with a composition shown in Table 17. Fat and muscle were removed from pork loin, and minced at 5 mm to be used as lean hog. According to each composition, additives were measured, mixed with a food processor, filled into a vinyl chloride tube and heated at 75'C for 30 min. [0172] [Table 17] Raw material TEST 1 TEST2 TEST 3 Control Lean hog (%) 83.0 83.0 83.0 83.0 NaCl(%) 2.0 2.0 2.0 2.0 Sodium Polyphate Na (%) 0.2 0.2 0.2 0.2 Sodium nitrite (ppm) 120 120 120 120 Sodium ascorbate (ppm) 300 300 300 300 water 14.5 14.5 14.5 14.5 Buckwheat crude protein 200 20 2 0 96 (ppm) Total (%) 99.762 99.744 99.7422 99.742 [0173] 2) Quantitative analysis by sandwich ELISA (salted meat model) Each salted meat model was ground until being homogenized with a food processor, and used as a sample for analysis. 1 g of sample was measured and taken, 19 g of PBST was added, and the mixture was stirred for 30 sec with a homogenizer. The resultant was centrifuged at 3, 000 rpm x 20 min, and the supernatant was filtered with a filter. 0.5 ml of the filtrates was measured to which 9.5 ml of PBST was added and used as a sample for ELISA. For a detection line, serial dilution of buckwheat crude protein using similarly PBST was used. (heated product model) Each heated product model was ground until being homologous with a food processor, and used as a sample for analysis. 1 g of sample was measured and taken, 19 g of PBS containing 1% SDS and 1% 2-mercaptoethanol was added, and the mixture was stirred for 30 sec with a homogenizer. Subsequently, a heating treatment was performed at 100*C for 1 hour. After cooling, centrifugation was performed at 3,000 rpm for 20 min, and the supernatant was filtered with a filter. 0.5 ml of the filtrates was measured to which 9.5 ml of PBST was added, and used as a sample for ELISA. For detection line, serial dilution of buckwheat crude protein which has been similarly treated with SDS 97 and 2-mercaptoethanol was treatment was used. [0174] For the analysis of buckwheat crude protein in meat product model by sandwich ELISA, the results of salted meat models are shown in Table 18, and the results of heat product models are shown in Table 19. [0175] [Table 18] TEST TEST2 TEST3 Control Added amount 200.0 20.0 2.0 0.0 (ppm) Assay value (ppm) 189.3 1 6.2 1.8 N.D.*2 Yield ( % ) * 1 94.6% 81.0% 90.5% *1 :( assay value / added amount) x100 *2 not detected [0176] [Table 19] TEST 1 TEST 2 TEST 3 Control Added amount 200.0 20.0 2.0 0.0 (ppm) Assay value (ppm) 156 . 6 18 . 0 2 . 6 N . D. Yield ( % ) * 1 78 . 3% 90 .0 % 133% [017 7] * 1 ( assay value / added amount ) x 100 * 2 not detected [0178] From the above results, buckwheat crude protein was 98 detectable in a high yield, even when it is a buckwheat crude protein which is non-heated such as a salted meat model, or a buckwheat crude protein which has been heat-denatured such as a heated product model. From these results, it was revealed that buckwheat in any state can be analyzed with a high sensitivity, regardless of whether it is non-heated (native) or heated (denatured), by combining MAbs bondable to native buckwheat proteins and MAbs bondable to denatured buckwheat crude proteins. [01791 3. Detection of denatured/native buckwheat crude proteins by immunochromatography 3-1 Materials and methods 1) Preparation of gold colloid labeled and conjugate pads PBW3MAb solutiton was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0). 500 pl of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react at room temperature for 30 min, 625 tl of 10% BSA solution was added and was further allowed to react for 15 min. Centrifugation was performed and it was prepared to OD525 = 1.0 with 1 % BSA solution. The resultant was applied to a glass wool conjugate pad (Nihon Millepore) to 68 ptl/cm 2 , and dried. [0180] 2) Preparation of antibody fixed membranes MAb solution of PBW1 and PBW2 was prepared to 8 mg/ml in PBS, mixed at a ratio of 1:1. The resultant was applied 99 linearly on a nitrocellulose membrane and dried. Then, the resultant was blocked for 1 hour, at 37*C with 10 mM phosphate buffer (pH 7.5) containing 1% skim milk, washed with 10 mM phosphate buffer (pH 7.5), and dried. [0181] 3) Construction and estimation of immunochromato strips A sample pad, a conjugate pad, an antibody-fixed membrane and an absorption pad prepared in the above were applied respectively, to make an immunochromatostrip. Meat product models prepared in the above were diluted appropriately and used as a test solution. [0182] 3-2 Results With the combination of membrane-applied MAbs, PBW1+PBW2, with gold-colloid labeled MAb PBW3, buckwheat protein could be detected up to 50 ppb (2 ppm in foods) regardless of whether it is heated or non-heated. From these results, it was revealed that immunochromato stip that can respond to any case can be constructed, even when a buckwheat protein which has been contaminated during the manufacture process is the target, or when a product after heating is the target. [0183] When PBS containing 0.01 M of urea + 0.2% 2-mercaptothanol as a blank was dropped to a commercial immunochromato strip to detect allergens, a non-specific band appeared, and it was tested as false positive. Thus, a protein denaturant to detect effectively allergens from food protein denatured by heating and the like, could not 100 be used, and there was a possible risk that subjects detectable as allergens would be limited to a very narrow range. Example 5 [0184] 1. Establishment of anti-Ara hlMAbs 1-1 Materials and methods 5-fold amount of 20 mM bis-tris-propane buffer (pH 7.2) was added to commercial raw peanuts. The mixture was stirred for 2 h at room temperature, centrifuged at 3000 x g, and the precipitates and oil content were removed. The obtained water-soluble fractions were further centrifuged at 1000 x g, to obtain supernatants. The supernatants were further purified by using Source Q (Amsharm Pharmacia) with 20 mM bis-tris-propane buffer (pH 7.2) and linear gradient of NaCl (0-1 M). The purified Ara hl fractions were dialyzed with distilled water, lyophilized, and used as denatured Ara hl (hereinafter referred to as NAhl). Further, for denatured Ara hi (hereinafter referred to as DAhl), 10 mg of Nahl was measured, 6 g of urea, 0.2 ml of 2-mercaptoethanol(hereinafter referred to as 2-ME), 1 ml of 50mM of Tris-HCl buffer solution (pH8.6) and 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, which was heated at 100*C in an oil bath to perform denaturation treatment. Subsequently, dialysis was performed followed by lyophilization. 0.1% DAhl solution and 0.1% DAhl solution were prepared by using these lyophilizates with saline and aliquoted at 500 pl 101 into 1ml-volume Eppendorf tubes, to make an antigen solution. The solution was store by freezing at -20'C until immunization. [0185] 2) Immunization As test animals, 5 BALB/c mice (CLEA Japan) of 5 weeks-old were used. For the primary immunization, an emulsion prepared by adding a complete Freund's adjuvant (Difco) to an Eppendorf tube each filled with 500 tl of 0.1% NAhl solution and 0.1% DAhl solution at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 ptl per mouse. Further, additional immunizations were performed twice at 3 weeks interval. For immunization, an emulsion prepared by adding an incomplete Freund's adjuvant (Difco) to Eppendorf tubes each filled with 500 il of 0.1% Nahl solution and 0.1% DAhl solution at an equal amount, and stirring in a vortex mixer was used. The emulsion was injected intraperitoneally in an amount of 150 [l per mouse. [0186) 3) Measurement of antibody titer in blood One week after injecting NAhl solution or DAh solution as the primary or additional immunization, blood was collected from tail vein of each BALB/c mouse. The blood collected was allowed to stand for 2 hours at room temperature, centrifuged to obtain serum. 10-fold serial dilution of these sera was prepared, and the anti-Nahl antibody titer and anti-DAhl antibody titer in mouse blood 102 were examined by non-competitive ELISA. Meanwhile, alkaline phosphatase labeled-anti mouse IgG (H+L) antibodies (Jackson ImmunoResearch Laboratories Inc.) were used as secondary antibodies. [0187] 4) Preparation of hybridomas Hybridomas were prepared according to the method of Keller and Milstein (1975). In other words, 100 pl of 0.1% Nahl solution and 0.1% DAhl solution were injected to tail-vein to a mouse whose antibody titer has sufficiently increased. Spleen was extracted from the mouse 4 days later, axenically. Spleen was extracted axenically from the mouse 4 days after intravenous injection. The spleen was chopped, subsequently washed with RPMI 1640, allowed to pass through a sterilized nylon mesh (Cell Strainer, 70 mm, Becton Dickinson), to obtain a spleen cell suspension. Spleen cells were harvested by a centrifugation at 1,000 rpm x 10 min, and the cells were counted after resuspending in RPMI 1640. The spleen cell suspension and mouse myeloma cells (P3X63Ag8.653) were mixed such that the cell count becomes 10:1, and then centrifuged again at 1,000 rpm x 10 min to obtain a pellet. 45% polyethylene glycol with a mean molecular weight of 3,350 was dropped to the pellet to allow a cell fusion. RPMI 1640 was added to the cell solution, which was diluted. A pellet was obtained by centrifugation. A HAT selective medium in which 100 4M of hypoxanthine, 0.4 tM of aminopterin and 16 pM of thymidine was added to a medium for hybridoma (RPMIl640 medium containing 10% bovine fetal 103 serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 mg/ml of streptomycin) was added to the pellet. The resultant was aliquoted in 24-well cell culture plate (Becton Dickinson) to 5 x 106 cells/well, and was cultured at 37*C, in the presence of 5% Co 2 . [0188] 5) Cloning by limiting dilution Presence of hybridomas provided as primary antibodies for ELISA and producing Nahl or DAhl was examined in the culture supernatant of each well of cell culture plate. Hybridomas which tested positive against Nahl or DAhl by ELISA were transferred to a 96-well cell culture plate (Becton Dickinson) and cloned by limiting dilution to 0.9 cell/well. Meanwhile, as feeder cells, thymocytes of 4-weeks old BALB/c mouse were added to each well of the 96-well cell culture plate, to 5 x 106 cells/well. RPMI 1640 media containing 10% of bovine fetal serum, 40 mM of 2-mercaptoethanol, 100 U/ml of penicillin, 100 tg/ml of streptomycin were used for culturing cloned hybridomas. [0189] 6) Screening of antibodies To screen monoclonal antibodies, clones of different specificities were obtained by examining the difference of reactivity against 4 types, that is NAhl, DAhl, or native substances of peanut crude protein (hereinafter referred to as NP-e) and urea-treated (hereinafter referred to as DP-e). Further, for NP-e, 5-fold amount of 20mM bis-tris-propane buffer (pH 7.2) to peanuts, the 104 mixture was stirred for 2 hours at room temperature and centrifuged twice. Subsequently, the obtained supernatants were dialyzed and lyophilized. Further, for DP-e, 10 mg of NP-e was measured, 6 g of urea, 0.2 ml of 2-ME, 1 ml of 50 mM Tris-HCl buffer solution (pH 8.6) and 1.5 ml of distilled water were added. The resultant was covered with an aluminum cap, and heated at 100C for 1 hour in an oil bath to perform a denaturation treatment. Reactivity against NAhl, NP-e, DAhl or DP-e in the supernatant was investigated by non-competitive ELISA. [0190] 7) 7) Collection of ascitic fluid and purification of MAb According to Jones et al. (1990), 0.2 ml of incomplete Freund's adjuvant was injected to a BALB/c mouse intraperitoneally. One week after, 5 x 10' cells/well of cloned hybridomas per mouse were inoculated. After accumulation of ascitic fluid, fluid was collected with a syringe. The collected ascitic fluid was purified by Protein G column (Amersham pharmacia). [0191] 8) Characteristics of MAbs; Classes, subclasses and types of MAbs Solid phase method was used to determine the characteristics of anti-Nahl MAbs or anti-DAhl MAbs. As a solid phase method, a method comprising the steps of fixing Nahl, DAhl, NP-e or DP-e were previously in wells of cell culture plate and to allowing anti-Nahl MAbs or DAhl MAbs to these fixed antigens was used. Further, classes and subclasses of MAbs were determined according 105 to Monoclonal mouse immunoglobulin isotyping kit (Pharmingen) as IgG1, IgG2a, IgG2b, IgG3, IgM, IgA, IgL (K) and IgL (y) [0192] 9) Biotinylation of MAbs Purified MAbs were biotinylated to be provided to sandwich ELISA. By using 50 mM of carbonate buffer solution (pH 8.5), it was prepared to 20 mg/ml, 10 ptl of NHS-biotin solution dissolved at 3 mg/100 ml in DMSO was added, and the mixture was stirred and then allowed to stand for 2 hours by icing. Subsequently, it was replaced with PBS, to 20 mg/ml. [0193] 1-2 Results 1) Characteristics, classes and subclasses of anti-NAhl MAbs and DAhl MAbs 7 MAbs having specificity against NAhl, and 3 MAbs having specificity against DAhl were obtained. Specificity against each solid phased antigen is shown in Tables 20 and 21. [0194] [Table 20] Classes, MAbs NAhl DAhl NP-e DP-e subclasses, and types 203 + * - + - IgGl(K) 217(PAhl-1) + - + - IgGl(K) 223 + - + - IgGl(K) 236(PAhl-2) + + + + IgGl(K) 427 +- + - IgGl(K) 106 432 + + + + IgGl (K) 451 + + + + IgG1 (K) [01953 [Table 21] MAbs NAhl DAhl NP-e DP-e Classes, subclasses, and types 967 - * + - + IgGl(K) 970 - + - + IgG3(K) 971(PAhl-3) - + - + IgGl(K) [0196] 2) Combination conditions Each MAb which showed a positive reaction against solid phased antigen was used as solid-phased or biotinylated antibodies, to select combinations of MAbs for detecting NP-e and DP-e from the view point of detection sensitivity in sandwich ELISA. As a result, as a combination for detecting NP-e, a combination of plate fixed antibody PAhl-2 (FERM ABP-10270) with biotinylated antibody PAhl-l (FERM ABP-10269) was selected. Further, as a combination for detecting DP-e, a combination of plate fixed antibody PAh-2 with biotinylated antibody PAh 1-3 (FERM ABP-10271) was selected (Figs 19 and 20). 3) Detection of NP-e and DP-e in a MAb mixed system PAhl-2 (cell deposit number) to solid phase, PAhl-l (cell deposit number) for biotinilyation and PAhl-3 (cell deposit number) were mixed to confirm the detection sensitivity of NP-e and DP-e. Each MAb concentration was 107 set to 50 pg/ml. As a result, both NP-e and DP-e were detectable in a MAb mixed system (Figs. 21 and 22). 2. Dectection of peanut crude proteins in foods by sandwich ELISA With the combination of PAhl-1, PAhl-2 and PAhl-3 selected in the above 1., it was investigated whether peanut crude proteins in actual foods could be detected. [0197] 2-1 Materials and methods 1) Preparation of meat product models Meat products were selected as food models for quantitative test, and meat product models containing peanut crude proteins at each concentration were prepared with a composition shown in Table 22. Fat and muscle were removed from pork loin, and minced at 5 mm to be used as lean hog. According to each composition, additives were measured, mixed with a food processor, filled into a vinyl chloride tube and heated at 75'C for 30 min. [0198] (Table 22] Raw material TESTl TEST2 TEST3 Control Lean hog (%)83.0 83. 0 83.0 83_.0 NaCl () 2.0 1 2.0 2 0 12.0 [0199] Sodium polyphosphate (%) 0.2 0.2 0.2 0.2 Sodium nitrite (ppm) 120 120 120 120 Sodium ascorbate (ppm) 300 300 300 300 water 14.5 14.5 14.5 14.5 108 Sodium casein (ppm) 200 20 2 0 Total (%) 99.762 99.744 99.7422 99.742 [02001 2) Quantitative analysis by sandwich ELISA (salted meat model) Each salted meat model was ground with a food processor until being homologous, and used as a sample for analysis. 1 g of sample was measured and taken, 19 g of PBST was added, and the mixture was stirred for 30 sec with a homogenizer. The resultant was centrifuged at 3000 rpm x 20 min, and the supernatant was filtered with a filter. 0.5 ml of the filtrates was measured, 9.5 ml of PBST was added and used as a sample for ELISA. For a detection line, serial dilution of peanut crude protein using similarly PBST was used. (heated product model) Each heated product model was ground until being homologous with a food processor, and used as a sample for analysis. 1 g of sample was measured and taken, 19 g of PBS containing 1M of urea and 0.1% 2-ME was added, and the mixture was stirred for 30 sec with a homogenizer. Subsequently, a heating treatment was performed at 100*C for 1 hour. After cooling, centrifugation was performed at 3,000 rpm for 20 min, and the supernatant was filtered with a filter. 0.5 ml of the filtrates was measured, 9.5 ml of PBST was added, and used as a sample for ELISA. For detection line, serial dilution of peanut crude protein which has been similarly treated with 1M urea and 0. 1% 2-ME 109 was used. Further, by using PBST it was extracted from sample for analysis, and was compared with when peanut crude protein dissolved in PBST was used as a detection line, and not using urea and 2-ME. [0201] 2-2 Results The analysis results of peanut crude proteins in meat product models by sandwich ELISA are shown in Table 23 for salted meat models, in Table 24 for heated product models, and in Table 25 for those which have been extracted only with PBST. [0202] [Table 23) TEST TEST2 TEST3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 206.0 18.4 1.8 N.D.*2 Yield ( %)*1 103.0 92.0 90.0 *1 :( assay value / added amount ) x 100 * 2 :not detected [0203] [Table 24] 'TEST 1 TEST 2 TEST 3 Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) 137 .0 19. 5 10. 3 N . D . *2 Yield (%) *1 68.5 97.5 515.0 *1 :( assay value / added amount ) x 100 * 2 :not detected [0204] [Table 25] 110 TEST 1 TEST 2 TEST 3 [Control Added amount (ppm) 200.0 20.0 2.0 0.0 Assay value (ppm) N. D. *2 N. D. N. D. N. D. Yield (%) *1 - - [0205] From the above results, peanut protein was detectable in a high yield, even when it is a peanut crude protein which is not heated such as a salted meat model, or a peanut crude protein which has been heat-denatured such as a heated product model. From these results, it was revealed that peanut can be analyzed with a high sensitivity, regardless of whether it is non-heated (native) or heated (denatured), by combining MAbs bondable to native peanut proteins and MAbs bondable to denatured peanut crude proteins. Further, it was revealed that it was effective to use urea and 2-ME for extracting peanut crude proteins from foods, and that it is necessary to be bondable to Ahl which has been denatured with urea. [0206] 3. Detection of denatured/native peanut crude protein by immunochromatography 3-1 Materials and methods 1) Preparation of gold colloid labeled and conjugate pads MAb solution of PAhl-l and PAh 1-3 was prepared to 1 mg/ml with 2 mM of borate buffer solution (pH 9.0) . 500 ml of MAb solution was added to 5 ml of gold colloid solution (Sigma) which was previously prepared to pH 9.0 with 0.2 M carbonic potassium solution, and after allowing to react 111 at room temperature for 30 min, 625 tl of 10% BSA solution was added and was further allowed to react for 15 min. Centrifugation was performed and it was prepared to OD525 = 2.0 with 1 % BSA solution, at a ratio of 1:1. The resultant was applied to a glass wool conjugate pad to 68 pl/cm 2 , and dried. [0207] 2) Preparation of antibody fixed membranes MAb solution of PAh 1-2 was prepared to 4 mg/ml in PBS. The resultant was applied linearly on a nitrocellulose membrane, and dried. Then, the resultant was blocked for 1 hour at 370C with 10 M phosphate buffer (pH 7.5) containing 1% skim milk, washed with 10mM phosphate buffer (pH 7.5) and dried. [0208] 3) Construction and estimation of immunochromato strips A sample pad, a conjugate pad, an antibody-fixed membrane and an absorption pad prepared in the above were applied respectively, to make an immunochromatostrip. Meat product models prepared in the above 2. were diluted appropriately and used as a test solution. [0209] 3-2 Results With the combination of membrane-applied MAb PAhl-1, with gold-colloid labeled MAbs PAhl-l and PAhl-3, peanut crude proteins could be detected up to 50 ppb (2 ppm in foods) regardless of whether it is heated or non-heated. From these results, it was revealed that immunochromato stip that can respond to any case can be constructed, when 112 a peanut protein which has been contaminated during the manufacture process is the target, or when a product after heating is the target. [0210] When PBS containing 0.01 M of urea and 0.2% 2-ME as a blank was dropped to a commercial immunochromato strip to detect allergens, a non-specific band appeared, and it was tested as false positive. Thus, a protein denaturant to detect effectively allergens from food protein denatured by heating and the like, could not be used, and it was estimated with fear that subjects detectable as allergen would be limited within a very narrow range. Industrial Applicability [02111 According to the present invention, in a immunological method for detecting milk allergens, albumen allergens, flour allergens, buckwheat allergens and peanut allergens contained in foods, these allergens can be detected accurately, quantitatively and qualitatively regardless of whether it is denatured/native. [0212] Although a preferred embodiment of the present invention has been described in the foregoing detailed description, it will be understood that the invention is not limited to the embodiment disclosed, but is capable of numerous rearrangements, modifications and substitutions without departing from the scope of the invention. [0213] Throughout this specification the word "comprise", or variations such as "comprises" or "comprising" will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps. [0214] All publications mentioned in this specification are herein incorporated by reference. Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed in Australia or elsewhere before the priority date of each claim of this application.
(FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PaslCN1 FERM ABP-10263 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004 (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 11A (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PaslCN2 FERM ABP-10264 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004 (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 11r (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PLG1 FERM ABP-10281 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 116 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PLG2 FERM ABP-10282 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 117 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PLG3 FERM ABP-10283 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PNOAl FERM ABP-10265 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004(the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 119 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PNOA2 FERM ABP-10266 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004(the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 120 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PDOAl FERM ABP-10275 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PDOA2 FERM ABP-10276 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamacka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PNOM1 FERM ABP-10279 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 123 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PNOM2 FERM ABP-10280 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 124 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PDOM1 FERM ABP-10277 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PDOM2 FERM ABP-10278 Ii. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 126 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 Ii. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PGL1 FERM BP-10267 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004 (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Hiqashi 1-chomre, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 (FORM 7) (pursuant to Rule 7. 1) RECEIPT TN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MITCROORGANISM Identification Reference Given by the Depositor: Accession Number: CGL2 FERM BP-10268 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorqanism under I above, on III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on September 7, 2004 (the date of the original deposit) . IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DI RECTOR Address: AIST Tsukuba Central G, 1-1, Hiqashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 100 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PBW1 FERM ABP-10272 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2006. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 129 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashici 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PBW2 FERM ABP-10273 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2006. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 130 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PBW3 FERM ABP-10274 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2006. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 1 :21 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PAhl-1 FERM ABP-10269 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2006. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 132 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PAhl-2 FERM ABP-10270 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 133 (FORM 7) (pursuant to Rule 7.1) RECEIPT IN THE CASE OF AN ORIGINAL DEPOSIT DEPOSITOR: Name: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou Address: 17-4, Higashioi 3-chome, Shinagawa-ku Tokyo 140-8529 I. IDENTIFICATION OF MICROORGANISM Identification Reference Given by the Depositor: Accession Number: PAhl-3 FERM ABP-10271 II. RECEIPT OF REQUEST OF ORIGINAL DEPOSIT This International Depositary Authority has received the microorganism under I above, on February 24, 2005. III. RECIEPT OF REQUEST FOR TRANSFER This International Depositary Authority has received the microorganism under I above deposited on (the date of the original deposit). IV. INTERNATIONAL DEPOSITARY AUTHORITY Name: International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Representative: Masakazu Yamaoka (sealed) DIRECTOR Address: AIST Tsukuba Central 6, 1-1, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan Date: February 24, 2005 134 FORM 7 (pursuant to Rule 7) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.206 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director V. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) AcesoNubr FERM P-20206 PaslCN1 VI. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position VII. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 135 FORM 7 (pursuant to Rule 7) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.207 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director I. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) Accession Number: PaslCN2FERM P-20202 II. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position III. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 136 kUKM / (pursuant to Rule /) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.208 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director I. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) Accession Number: FERM P-20208 PNOA1 II. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position III. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 137 FORM 7 (pursuant to Rule 7) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.209 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director I. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) AcesoNubr PNOA2FERM P-20209 II. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position III. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 138 FORM 7 (pursuant to Rule 7) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.210 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director I. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) Accession Number: PGL1 FERM P-20210 II. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position III. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 139 rut u / (pursuant to Kule /) NOTICE OF ACCEPTANCE COMMUNICATION NO: 16 SAN SEI KI No.211 DATE OF COMMUNICATION: September 7, 2004 TO: PRIMA MEAT PACKERS, LTD. Representative; Mr. Junji Kinou International Patent Organism Depositary National Institute of Advanced Industrial Science and Technology Masakazu Yamaoka Director I. IDENTIFICATION OF MICROORGANISM (Identification Reference Given by the Depositor) AcesoNubr PGL2 FERM P-20211 II. A SCIENTIFIC DESCRIPTION AND/ OR PROPOSED TAXONOMIC POSITION The microorganism identified under I above was accompanied by a document stating the following item(s). X A Scientific Property X Taxinomic Position III. RECIEPT AND ACCEPTANCE This International Depositary Authority accepts the microorganism identified under I above, which was received on September 7, 2004. 140 8/10 Copy in writing (Note: electronic data is the original text) [This sheet does not constitute a part of the international application, and is not counted as sheets of the international application.] 22 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 22-1 Paragraph number 0042 22-3 Identification of deposit 22-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (IPOD) 22-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibaraki-ken, 305-8566 Japan 22-3-3 Date of deposit September 7, 2004 22-3-4 Deposit number IPOD FERM P-20206 22-5 Designated states for this All of the designated states identification 23 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 23-1 Paragraph number 0042 23-3 Identification of deposit 23-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (IPOD) 23-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibarald-ken, 305-8566 Japan 23-3-3 Date of deposit September 7, 2004 23-3-4 Deposit number IPOD FERM P-20207 23-5 Designated states for this All of the designated states identification 24 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 24-1 Paragraph number 0042 24-3 Identification of deposit 24-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (IPOD) 24-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibaraki-ken, 305-8566 Japan 24-3-3 Date of deposit September 7, 2004 24-3-4 Deposit number IPOD FERM P-20208 24-5 Designated states for this All of the designated states identification 141 9/10 Copy in writing (Note: electronic data is the original text) [This sheet does not constitute a part of the international application, and is not counted as sheets of the international application.] 25 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 25-1 Paragraph number 0042 25-3 Identification of deposit 1 25-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (IPOD) 25-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibaraki-ken, 305-8566 Japan 25-3-3 Date of deposit September 7, 2004 25-3-4 Deposit number IPOD FERM P-20209 25-5 Designated states for this All of the designated states identification 26 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 26-1 Paragraph number 0042 26-3 Identification of deposit 26-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (POD) 26-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibarald-ken, 305-8566 Japan 26-3-3 Date of deposit September 7, 2004 26-3-4 Deposit number IPOD FERM P-20210 26-5 Designated states for this All of the designated states identification 27 The following identification relates to microorganisms or biological materials described in the detail description of the invention. 27-1 Paragraph number 0042 27-3 Identification of deposit 27-3-1 Name of depositary IPOD International Patent Organism Depositary institution National Institute of Advanced Industrial Science and Technology (IPOD) 27-3-2 Address of depositary Central 6, Higashi 1-chome, Tsukuba-shi, institution Ibarald-ken, 305-8566 Japan 27-3-3 Date of deposit September 7, 2004 27-3-4 Deposit number IPOD FERM P-20211 27-5 Designated states for this All of the designated states _identification To be filled by the Receiving Office 0-4 This sheet has been received with the international application (yes/no) 0-4-1 I Authorized staff
Claims (12)
1. A method for detecting flour allergens, wherein an anti-flour gliadin monoclonal antibody recognizing a native 5 flour gliadin and a flour gliadin solubilized with a denaturant is used.
2. A method for detecting flour allegens, wherein 2 types of anti-flour gliadin monocolonal antibodies recognizing a 10 native flour gliadin and a flour gliadin solubilized with a denaturant, and recognizing different epitopes are used in combination.
3. The method for detecting flour allergens according to 15 claim 1 or 2, wherein the anti-flour gliadin monoclonal antibody recognizes a native flour gliadin, a reduced carboxymethylated flour gliadin, a flour gliadin solubilized with 0.1 M acetate, a flour gliadin solubilized with 70% ethanol, and a flour gliadin solubilized with a 20 denaturant.
4. The method for detecting flour allergens according to any one of claims 1 to 3, wherein the anti-flour gliadin monoclonal antibody is the anti-flour gliadin monoclonal 25 antibody PGL1 produced by hybridoma (FERM BP-10267) and/or the anti-flour gliadin monoclonal antibody PGL2 produced by hybridoma (FERM BP-10268).
5. The method for detecting flour allergens according to 30 any one of claims 1 to 4, wherein the native flour gliadin, the reduced-carboxymethylated flour gliadin, the flour gliadin solubilized with 0.1 M acetate, the flour gliadin solubilized with 70% ethanol and the flour gliadin solubilized with a denaturant in foods can be analyzed 35 qualitatively and quantitatively even at a concentration in a range of 10 to 100 ppb by sandwich ELISA. 143
6. A kit for detecting flour allergens comprising an anti flour gliadin monoclonal antibody recognizing a native flour gliadin and a flour gliadin solubilized with a 5 denaturant.
7. A kit for detecting flour allergens comprising 2 types of anti-flour gliadin monoclonal antibodies recognizing a native flour gliadin and a flour gliadin solubilized with a 10 denaturant, and recognizing different epitopes.
8. The kit for detecting flour allergens according to claim 6 or 7, wherein the anti-flour gliadin monoclonal antibody recognizes a native flour gliadin, a reduced 15 carboxymethylated flour gliadin, a flour gliadin solubilized with 0.1 M acetate, a flour gliadin solubilized with 70% ethanol and a flour gliadin solubilized with a denaturant. 20
9. The kit for detecting flour allergens according to any one of claims 6 to 8, wherein the anti-flour gliadin monoclonal antibody is the anti-flour gliadin monoclonal antibody PGL1 produced by hybridoma (FERM BP-10267) and/or the anti-flour gliadin monoclonal antibody PGL2 produced by 25 hybridoma (FERM BP-10268).
10. The kit for detecting flour allergens according to any one of claims 6 to 9, wherein at least one of the 2 types of monoclonal antibodies recognizing different epitopes is 30 a monoclonal antibody labeled with gold colloid used for immunochromatography.
11. Anti-flour gliadin monoclonal antibody PGL1 produced by hybridoma (FERM BP-10267). 35
12. Anti-flour gliadin monoclonal antibody PGL2 produced 144 by hybridoma (FERM BP-10268). 145
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012201658A AU2012201658B2 (en) | 2004-03-05 | 2012-03-21 | Method of detecting allergen |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004-063071 | 2004-03-05 | ||
| JP2004-285542 | 2004-09-29 | ||
| JP2004-285543 | 2004-09-29 | ||
| AU2009200519A AU2009200519B2 (en) | 2004-03-05 | 2009-02-11 | Method of detecting allergen |
| AU2012201658A AU2012201658B2 (en) | 2004-03-05 | 2012-03-21 | Method of detecting allergen |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009200519A Division AU2009200519B2 (en) | 2004-03-05 | 2009-02-11 | Method of detecting allergen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012201658A1 true AU2012201658A1 (en) | 2012-04-12 |
| AU2012201658B2 AU2012201658B2 (en) | 2013-01-24 |
Family
ID=46614718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012201658A Ceased AU2012201658B2 (en) | 2004-03-05 | 2012-03-21 | Method of detecting allergen |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2012201658B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116794296A (en) * | 2023-08-15 | 2023-09-22 | 美维仕(北京)健康管理有限公司 | Method and kit for detecting sensitization of hydrolyzed formula food |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1294903C (en) * | 1987-07-08 | 1992-01-28 | Commonwealth Scientific And Industrial Research Organisation | Monoclonal antibodies and test method for detection of gluten in foods |
-
2012
- 2012-03-21 AU AU2012201658A patent/AU2012201658B2/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116794296A (en) * | 2023-08-15 | 2023-09-22 | 美维仕(北京)健康管理有限公司 | Method and kit for detecting sensitization of hydrolyzed formula food |
| CN116794296B (en) * | 2023-08-15 | 2024-03-08 | 美维仕(北京)健康管理有限公司 | Method and kit for detecting sensitization of hydrolyzed formula food |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012201658B2 (en) | 2013-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009200519B2 (en) | Method of detecting allergen | |
| JP2009271091A5 (en) | ||
| Hnasko et al. | Sensitive and selective detection of peanut allergen Ara h 1 by ELISA and lateral flow immunoassay | |
| US7297500B2 (en) | Use of Troponin I as a species marker protein for meat speciation in both raw and heat-processed products | |
| Dooper et al. | Monoclonal antibodies against the candidate lupin allergens α-conglutin and β-conglutin | |
| CN109705216B (en) | A kind of anti-bovine skeletal muscle troponin I monoclonal antibody and its application | |
| AU2012201658B2 (en) | Method of detecting allergen | |
| Klassen et al. | Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody | |
| KR20230165063A (en) | Monoclonal Antibody Specifically Binding to Enrofloxacin and Kit for Detecting Enrofloxacin | |
| CN114214288A (en) | Zearalenone monoclonal antibody hybridoma cell strain and application thereof | |
| JP4597172B2 (en) | Antibody to bovine myoglobin partial peptide, test method using the antibody, and test kit | |
| JP2007527523A (en) | Reagent, method and kit for detecting feed enzymes | |
| US7915052B2 (en) | Immunoglobulin peptides against heated bovine blood | |
| KR102874522B1 (en) | Monoclonal Antibody Specifically Binding to Dexamethasone and Kit for Detecting Dexamethasone | |
| JP4954009B2 (en) | Allergen detection method and detection kit | |
| JP4866190B2 (en) | Soybean detection kit in food | |
| JP2007108169A (en) | Method and kit for detecting allergen | |
| KR20230149702A (en) | Monoclonal Antibody Specifically Binding to Flunixin and Kit for Detecting Flunixin | |
| TWI527903B (en) | Hybridoma cell line producing monoclonal antibodies against the bont/a, the monoclonal antibodies therefrom, and reagent and elisa kit comprising the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |